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Abstract 
	  
Epigenetic programming facilitates the adaptation of an organism to changes in the 
environment through lasting alterations in gene expression that underlie certain physical and 
behavioral phenotypes. Exposure to adverse events in early postnatal life is known to increase 
the risk for stress-related psychiatric disorders later on. Our previous studies showed that 
early-life stress (ELS) in mice caused by periodic infant-mother separation (MS) leads to 
increased hyperactivity of the HPA axis, reduced glucocorticoid feedback inhibition, and 
depressive-like behavior. Moreover, our work revealed ELS-induced hypomethylation of the 
arginine vasopressin (Avp) gene enhancer and pro-opiomelanocortin (Pomc) promoter. 
The aim of the study was to investigate whether ELS can also lead to epigenetic programming 
of the mouse glucocorticoid receptor (GR, Nr3c1). GR is a major feedback regulator of the 
hypothalamic-pituitary adrenal (HPA) stress axis and its expression is regulated by multiple 
promoters associated with its5’ untranslated first exons. Given the fact that the mouse GR 
promoter was only partly characterized, we aimed to determine its genomic structure. In 
addition, tissue distribution and absolute quantification of newly identified alternative first 
exon transcripts were analysed. Although most of the first exon transcripts were found to be 
widely expressed, some of them are shown to be differentially regulated by growth factor- and 
depolarization-induced signaling. 
In the present work we show also that mice with a history of maternal separation display up-
regulated GR mRNA levels. This observation was confined to Crh-producing neurons in the 
hypothalamic paraventricular nucleus (PVN), which are principal effectors of the stress 
response. Moreover, elevated levels of GR are shown to be responsible for stronger induction 
of its downstream target genes (Fkbp5, Sgk1, and DUSP1), which suggests an enhanced 
transcriptional activity of the GR in ELS mice. This effect is supported by a higher occupancy 
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of the GR at the glucocorticoid response elements (GREs), following corticosterone injection 
(i.p.).  
Finally, we report here that an enhanced level of GR expression in ELS mice is accompanied 
by an increased methylation of specific CpG residues at the CpG island shore region of the 
GR promoter. These ELS-responsive CpGs comprise a DNA binding site for the 
transcriptional repressor Yin Yang 1 (YY1). Given the high homology of the mouse and 
human GR promoter, and the conservation of the YY1 binding site, we conducted a 
methylation analysis of the hGR CpG island shore region in peripheral tissues and post 
mortem brain samples. Our findings might serve as a basis for comparing the methylation 
patterns in tissues from control subjects and patients with stress-related brain disorders. 
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1.1 The role of epigenetic mechanisms in psychiatry 
Epigenetics refers to the study of changes in gene expression that occur independently of 
alterations in primary DNA sequence. Importantly, epigenetic modifications remain stable 
during cell division and can be inherited across generations (Bird et al. 2007). Changes at the 
epigenome are essential for all eukaryotic organisms and are key mechanisms to control 
biological processes such as: 
ü genome reprogramming during early development (Li et al. 2002; Reik et al. 2007); 
ü cellular differentiation in order to establish cell- and tissue-specific gene expression 
patterns. This leads to phenotypically different tissues, although each cell in the body harbors 
the same genetic information (Ng et al. 2008); 
ü adaptation of the developing and mature organism to a wide range of environmental 
cues (e.g. stress, nutrition or drugs) (McGowan et al. 2009; Murgatroyd et al. 2009; Weaver 
et al. 2004); 
ü aging, which is associated with accumulation of epigenetic alterations over lifetime 
and contribute to a progressive decline in the function of adult tissues (López-Otín et al. 
2013). 
 
Major epigenetic mechanisms involved in gene regulation are: 
ü direct postsynthetic chemical modification of DNA by cytosine methylation (and 
demethylation) in the context of cytosine-guanine dinucleotides (CpGs) (described below) 
(Jaenisch et al. 2003); 
ü post-translational modifications of histone proteins such as acetylation, methylation, 
phosphorylation, ubiquitination, sumoylation and ADP-ribosylation, which modulate 
chromatin structure and are associated with transcriptional states (open, transcriptionally 
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active chromatin, so called euchromatin, versus closed, inactive chromatin, so called  
heterochromatin) (Portela et al. 2010); 
ü small non-coding RNAs (microRNAs), which posttranscriptionally control the 
expression of their target genes by mRNA degradation or blocking of translation (Chuang et 
al. 2007; Sato et al. 2011)	  
 
Together, these processes orchestrate transcriptional activation or repression of genes in a 
context-dependent manner through changes in chromatin structure. Hereby, they determine 
the DNA accessibility to various proteins including those that recognize more directly such 
modifications and upon DNA binding and/or association with the chromatin confer 
transcriptional regulation (Jaenisch et al. 2003; Costa et al. 2008). While epigenetic 
modifications are required for normal development and an organism’s health, they can also 
contribute to pathological states.  Defects in the epigenetic machinery have been linked to 
various disorders, including cancer, psychiatric, neurological and autoimmune diseases 
(Bredy et al. 2010; Kaiser et al. 2010; Portela et al. 2010; Murgatroyd et al. 2012)	  
 
1.1.1 DNA methylation and demethylation 
In mammalian cells, DNA methylation is typically found at cytosine residues located at the 5’ 
position of the pyrimidine ring, in the dinucleotide 5´-CpG-3´ (Suzuki et al. 2008). Addition 
of a methyl group from S-adenosyl methionine (SAM) to cytosine is catalyzed by a family of 
DNA methyltransferases (Dnmts). Three members of this family contain enzymatic activity: 
Dnmt1, Dnmt3a, and Dnmt3b (Li et al. 2002). Ubiquitously expressed Dnmt1 is a 
maintenance methyltransferase that shows preference for hemi-methylated DNA, and initiates 
methylation of the complementary strand after DNA replication. Its role is to maintain pre-
existing methylation patterns in proliferating cells (Bird et al. 2002). De novo methylation is 
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mediated by Dnmt3a and Dnmt3b, which add methyl groups to previously unmodified DNA. 
These enzymes are highly expressed in early embryonic cells, down regulated after 
differentiation, and expressed at low levels in adult differentiated somatic cells. Dnmt3a and 
Dnmt3b are essential for normal development (Okano et al. 1999; Wu et al. 2010).  
Although, DNA methylation is a comparatively stable epigenetic mark when compared to 
histone modifications, accumulating evidence indicates its highly dynamic nature. The 
appropriate balance between methylated and unmethylated CpG residues is crucial for an 
organism’s health. At some developmental stages, e.g.; in the zygotic paternal genome during 
embryonic development, rapid DNA demethylation has been observed (Wu et al. 2010).  
Although enzymes which carry out DNA methylation are well defined, the pathway leading to 
the removal of a methyl group is not yet completely understood. It has been suggested that 
DNA methylation can be reversed by two distinct pathways, namely passive or active 
demethylation (Figure 1). Passive demethylation occurs by lack of de novo methylation 
following DNA replication and consequently leads to a dilution of this modification (Chen et 
al. 2011). On the other hand, active demethylation was proposed to be independent of cell 
division (Guo et al. 2011). Direct removal of the 5-methyl group from 5-methylocytosine (5-
mC) seems to be very unlikely, due to the high energetic barrier (Kohli & Zhang 2013), 
however, several potential multistep enzymatic pathways have been proposed. Recent reports 
suggest hydroxylation of 5-methylcytosine (5-mC) to 5-hydroxymethylcytosine (5-hmC), a 
reaction catalyzed by the family of ten-eleven translocation (TET) proteins, to represent a 
potential pathway. Subsequently, deamination is catalyzed by AID/APOBEC to convert 5-
hmC to 5-hydroxymethyl uracil (5hmU) for further processing by thymine DNA glycosylase 
(TDG) and the base excision repair machinery (BER) to regenerate unmodified cytosine (Wu 
et al. 2010). It has also been reported that TET-mediated enzymatic oxidation of 5mC to 
5hmC may lead to the formation of 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), 
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which then can be removed by the DNA repair pathway (Kohli et al. 2013). Moreover, it has 
been suggested that 5hmC contributes to passive demethylation, because is not recognized by 
DNMT1 and methyl-CpG binding proteins (Valinluck et al. 2007). 
In addition to a role in proliferating cells, the importance of dynamic DNA methylation 
changes has also been expanded to post-mitotic tissues, such as the brain. Post-mitotic 
neurons express DNMTs, which mostly decline after differentiation in other tissues (Moore et 
al. 2013).  Importantly, active de novo methylation and demethylation may occur in mature 
neurons in response to various cues, including behavioural stimulation (Guo et al. 2011). 
 
	  
 
Figure 1: Potential mechanisms for active DNA demethylation  
DNA methylation is established and maintained by DNA methyltransferases (maintenance DNMT1, and de novo 
DNMT3a and DNMT3b). DNA demethylation may occur via passive (e.g.; during replication) or active 
mechanisms. Active DNA demethylation is thought to involve hydroxylation of 5-metylocytosine (5mC) to 5-
hydroxymetylocytosine (5hmC) by ten-eleven translocation (TET) proteins. 5hmC can be next deaminated to 5-
hydroxymethyluracil (5hmU) by Aid/APOBEC deaminases. Alternatively, 5mhC can be converted by TET to 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC). In the end 5mhU, 5fC and 5caC are removed by 
glycosylases, such as TDG, and replaced with unmodified cytosine. 5hmC contributes to replication independent 
passive DNA demethylation, due to poor recognition by DNMT1. Adopted from (Wu et al. 2010). 
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Almost 80 % of all CpG sites are methylated and their genomic location often determines 
their methylation status. Across the mammalian genome, CpG dinucleotides are not randomly 
distributed, but often cluster in regions known as CpG islands (CGIs). CGIs are defined as 
regions of DNA with an average length of 200 – 4,000 bp, an CG content > 50%, and a ratio 
of observed CpG to expected CpG ≥65%. Typically, CpG islands are unmethylated, and are 
present within or close to the proximal promoter region of genes and often contain 
transcriptional starts sites (TSS). Approximately 60% of the mouse and human gene 
promoters are associated with an CGI (Bird et al. 2002; Deaton et al. 2011). For the majority 
of the genes, CpG island methylation leads to transcriptional repression. However, CGI 
methylation does not always reflect the level of expression (Bird et al. 2002). For example, 
genes that are tissue-specifically expressed may remain unmethylated in tissues, where the 
gene is not expressed (e.g.; MyoD in non-muscle tissues) (Bustos et al. 2009). In some cases, 
DNA methylation can lead to transcriptional activation of genes (e.g.; methylation at the 
imprinting control region of the insulin-like growth factor 2 gene at the paternal allele can 
activate its transcription) (Bartolomei et al. 2011). 
There are two primary mechanisms by which DNA methylation affects gene expression. 
Methylated cytosine residues can serve as a binding site for a variety of methyl-CpG-binding 
proteins (MBDs), which recruit additional proteins, e.g.; histone deacetylases (HDACs) or 
histone methyltransferases (HMTs). These proteins harbor enzymatic activities, which 
promote the formation of a condensed chromatin structure and lead to the suppression of gene 
expression. Alternatively, a methyl group can interfere with the recognition of DNA 
sequences by specific transcriptional factors at their binding site within gene regulatory 
regions (Bird et al. 2002; Li et al. 2002).  
Although, most studies focused so far on CGI methylation, recent findings revealed an 
additional relationship between gene expression and DNA methylation at a region termed 
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“CpG island shore”. CpG island shores are defined as regions of lower CpG density, which 
are located nearby CGIs (up to 2 kb upstream) and methylation at these site seems to occur in 
tissue-specific manner (Doi et al. 2009; Irizarry et al. 2009). 
 
1.1.2 Gene-environment (G x E) interactions 
It is well known that an individual’s phenotype does not only depend on its genetic 
background, but also on the synergistic interactions between genes and environmental cues. 
Recent studies indicate that epigenetic modifications can fulfill a role as mediator, which 
facilitates the adaptation of the organism to signals from the environment (including stress, 
smoking, physical activity, or diet, among others) at different periods in life (Figure 2). In 
contrast to the genome, which is rather stable over lifetime, the epigenome can be 
dynamically modulated by environmental factors, a phenomenon known as “environmental 
programming” (Murgatroyd et al. 2009). Hence, accumulation of epigenetic marks throughout 
life results in enduring alterations in expression of different genes and in consequence can 
modulate an adult physical and behavioural phenotype (López-Otín et al. 2013).	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Figure 2. Gene-environment interactions 
Prenatal, postnatal, pubertal, and/or adult exposure to environmental factors have the potential to induce changes 
in the epigenome. This can lead to stable alterations in gene expression and consequently affect the phenotype 
later in life. 
 
This view is supported by the studies of monozygotic twins (MZ), which have identical 
genomes, but distinct phenotypes. Epigenetic differences between MZ twins develop after 
birth and increase with age (Fraga et al. 2005). Some phenotypic variations of MZ twins, 
including the manifestation of psychiatric diseases in one of two genetically predisposed 
twins, may be potentially influenced by gene-environment interactions (Fraga et al. 2005; 
Petronis et al. 2006; Czyz et al. 2012). In this respect, valuable information is provided by 
studies of animals with identical genotypes. For instance, a well- known example of gene-
environment interaction is the agouti mouse model. In these mice, the color of the fur is 
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associated with the degree of methylation at the intracisternal A particle element (IAPs) at the 
promoter region of the agouti gene (the unmethylated state leads to yellow coat, whereas the 
methylated state leads to brown coat color). Interestingly, the methylation status of  the IAP 
can be modulated by maternal nutrition. For example, a diet rich or poor in methyl donors, 
affects regulation of agouti expression in the offspring, as indicated by the color of the 
offspring’s coat (Dolinoy et al. 2008).  
 
1.1.3 Early-life stress (ELS)  
Gene-environment interactions during the pre- and postnatal period are especially important 
in shaping later adult phenotype. Studies in animals and humans have shown that different 
early life events, in particular stress, may affect the developing brain and promote long lasting 
changes in neural structure and function. ELS (e.g.; sexual or psychical abuse, lack of parental 
care) is an important risk factor for the development of stress-related psychiatric disorders, 
such as anxiety, major depression (MDD), and post-traumatic stress disorders (PTSD) 
(Cutajar et al. 2010; Heim et al. 2012; Labonte et al. 2012; Lupien et al. 2009; Raabe et al. 
2013). Child abuse has been shown to be correlated with more frequently occurring suicide 
attempts in adulthood (McGowan et al. 2009), cognitive difficulties (Lupien et al. 2009), 
alcohol and substance abuse (Anda et al. 2006) or inappropriate aggression (Ford et al. 2010). 
Altogether, these findings suggest that the postnatal period is an especially vulnerable time 
window during which the brain is highly plastic and sensitive to long-term programming 
(Lupien et al. 2009). However, the molecular mechanisms mediating these effects are still 
poorly understood. 
In order to investigate human traumatic events and to better understand the consequences of 
early life adversity, different animal models have been proposed. Given the importance of 
postnatal maternal care in rodents, a common approach to induce ELS is the manipulation of 
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the relationship between the pups and their mother. Periodic infant-mother separation (MS) is 
a well-established paradigm which is applied for 3 hours per day, starting at post-natal day 1 
(PND1) and terminated about PND10 in mice (PND2- PND14 in rats) (Lupien et al. 2009; 
Murgatroyd et al. 2009). Maternal separation is reported to be associated with long lasting 
hyperactivity of the HPA axis, impaired learning and memory, and an increased depression-
like behaviour in adulthood (Murgatroyd et al. 2009). Another approach to test the effects of 
ELS is maternal deprivation (MD), a single 24-h episode applied during the first 2 weeks of 
life. This paradigm is shown to induce hyperactivity of the HPA axis (Chen et al. 2012), 
affect the rat’s hippocampal structure (Oomen et al. 2010), and to modify cognitive functions 
in adulthood (Oitzl et al. 2000). Lastly, as shown by Meaney and colleges, Long-Evans rat 
dams can be classified either as high- or low licking and grooming (LG) and arched-back 
nursing (ABN) mothers due to naturally occurring variations in maternal care. In this model, 
the quality of maternal care has a strong impact on offspring’s anxiety behaviour in adulthood 
(Caldji et al. 1998) and epigenetic status of the glucocorticoid receptor gene promoter 
(Weaver et al. 2004) (for details see section 1.3.4 ” Epigenetic programming of GR”).  
 
Furthermore, it is important to note that some effects of adverse early life events are 
reversible through appropriate, timely interventions (e.g.; pharmacological treatment or 
behavioural manipulations). For example, foster care applied in mid childhood, was shown to 
improve partly cognitive defects of young institutionalized children (Smyke et al. 2010). 
Furthermore, the cross-fostering method used in Long-Evans rats (offspring of low-LG-ABN 
mothers reared by high-LG-ABN dams) was able to reverse  the endocrine and behavioural 
responses to deficits in maternal care (Weaver et al. 2004). These observations support the 
important influence of maternal parenting behavior on the offspring’s epigenome.  
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Moreover, the study of Murgatroyd et al. (2009) revealed that chronic application of the 
selective AVP V1b (SSR149415) receptor antagonist partly normalized ELS-induced 
neuroendocrine and behavioural phenotypes in adult mice (Murgatroyd et al. 2009). Lastly,  
supplementation with the amino acid L-methionine (a precursor of SAM) reversed the effect 
of variations in maternal care on epigenetic marking of GR and HPA-axis responsiveness to 
stress in rats (Weaver et al. 2005).  
 
1.2 The hypothalamic-pituitary-adrenal (HPA) axis coordinates the response to stress 
Stress induces multiple biological responses (e.g.; neuronal, hormonal and immunological) 
which allow an organism to cope with and adapt to a challenge. An important part of this 
response is the activation of hypothalamic–pituitary–adrenal (HPA) axis (Figure 3). Briefly, 
following a physical or emotional stress neurons in the parvocellular division of the 
hypothalamic paraventricular nucleus (PVN) secrete two types of peptides into the 
hypothalamo-hypophysial portal system: corticotropin-releasing hormone (CRH) and arginine 
vasopressin (AVP). These factors stimulate the anterior pituitary to synthesize pro-
opiomelancortin (POMC), which is the precursor of adrenocorticotropic hormone (ACTH), 
among other peptides. AVP on its own has little potential to stimulate ACTH secretion, 
whereas the synergistic interaction with CRH regulates efficiently ACTH release 
(Charmandari et al. 2005). ACTH, secreted into the bloodstream, induces release of 
corticosteroids (cortisol in human, corticosterone in rodents) from the adrenal glands 
(Aguilera, 2011). Glucocorticoids (GCs) are small steroid molecules which are able to easily 
penetrate through cell membranes into every cell of the body, and subsequently exert their 
effects by binding to two specific, ligand-gated receptors: the mineralocorticoid receptor 
(MR) and the glucocorticoid receptor (GR). Both receptors reside in their unbound state in the 
cytosol and translocate upon binding of their respective ligands to the nucleus where they act 
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as transcription factors. Hereby, the MR shows an about 10-fold higher affinity to GCs than 
the GR (de Kloet et al. 2005). Thus, the MR is predominantly occupied at low GC levels, 
while the GR needs higher GC concentrations to be fully activated (Zanchi et al. 2010). 
Moreover, both receptors display different expression patterns: GRs are widely expressed 
with high levels in pituitary corticotropes and throughout the brain, especially in the 
hippocampus and hypothalamic neurons, while MRs are mainly limited to the hippocampus 
and to lesser extend to the hypothalamus (Groeneweg et al. 2011; Goncharova et al. 2013). 
Following activation, the stress system is inhibited at multiple sites in the brain 
(hippocampus, cortex, and hypothalamus) and the anterior pituitary. GCs as an end product 
self-limit their secretion through corticosterone-mediated negative feedback mechanisms 
(Figure 3). Prolonged activation of the HPA axis and sustained secretion of cortisol 
(corticosterone) become harmful for peripheral tissues and the brain. Although, 
glucocorticoids are absolutely necessary for many vital functions and prepare the organism 
for proper endocrine, metabolic and behavioural responses to environmental challenges, their 
high levels across long time periods may result in pathological states and subsequently lead to 
health problems later in life, including obesity, insulin resistance, osteoporosis, cardiovascular 
problems, as well as  mood and cognitive impairments (de Kloet et al. 2005). Thus, efficient 
activation of the stress response as well as its termination are necessary to prevent the 
development of pathological states.  
 
CHAPTER 1   INTRODUCTION 	  
	  
	  
 
 
Figure 3: Regulation of HPA axis in response to stress 
Activation of the HPA axis leads to secretion of corticotropin releasing hormone (CRH) and arginine vasopressin 
(AVP) from the hypothalamic PVN. These neuropeptides stimulate the anterior pituitary to release 
adrenocorticotropin (ACTH), which in turn acts on the adrenal cortex to secrete glucocorticoids (cortisol in 
human or corticosterone in rodents). Glucocorticoids (GCs) exert their effect by binding to glucocorticoid (GR) 
and mineralocorticoid receptors (MR). GCs act back on the hippocampus, hypothalamus, and pituitary gland to 
attenuate the stress response by a negative feedback loop. The positive (+) forward regulation of the HPA axis is 
shown in green; while the negative (-) feedback regulation by GRs is indicated in red. Adopted from 
(Papadopoulos et al.  2012) 
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Clinical studies reported that hyperactivity of the HPA axis, characterized by basal 
hypercortisolemia, is detected in a large proportion of patients suffering from mood disorders 
(e.g.; MDD) (Swaab et al. 2005). These conditions are thought to be mediated (at least in 
part) by an impaired negative feedback inhibition, possibly due to an altered function or 
expression of GRs in the hippocampus and/or the hypothalamus (Holsboer et al. 2000; 
Pariante et al. 2001; Zunszain et al. 2011). Indeed, post mortem studies revealed reduced 
levels of GR mRNA in the hippocampus of suicide completers with a history of childhood 
abuse (in comparison to suicide victims with no history of childhood abuse and control 
subjects) (Labonte et al. 2012). The glucocorticoid resistance hypothesis is also supported by 
results of the dexamethasone suppression (DST) or dex/CRH test (Holsboer et al. 2000). 
Dexamethasone (dex) is a potent synthetic glucocorticoid, which specifically binds to GRs, 
poorly penetrates the blood brain barrier (BBB) in mouse and human, and thus acts primarily 
at the pituitary level to inhibit ACTH and corticosteroids secretion (de Kloet et al. 2005). For 
example, Heim et al. (2008) have reported that dex administration leads to increased secretion 
of ACTH and cortisol in MDD patients with a history of childhood abuse [in comparison to 
non-abused/MDD and control subjects (Heim et al. 2008)]. All these reports suggest that early 
traumatic events affect the developing HPA axis and increase the susceptibility to psychiatric 
disorders later in life.	  
This view is supported by a number of rodent studies, although results obtained from animals 
are difficult to be extrapolated to humans. Murgatroyd et al. (2009) have shown that ELS in 
male mice leads to hyperactivity of the HPA axis, both under resting conditions and in 
response to an acute stressor, as indicated by increased plasma corticosterone levels. In 
addition, dexamethasone did not suppress plasma corticosterone levels in 3 month old mice 
with a history of ELS as compared with controls. Moreover, ELS mice display enhanced 
levels of Avp in the PVN (Murgatroyd et al. 2009) and pituitary pro-opiomelancortin  (Pomc) 
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(Y. Wu et al. 2014) throughout life. Changes in Avp expression associate with CpG 
hypomethylation at the Avp enhancer, which serves as a binding site for the methyl CpG–
binding protein 2 (Mecp2) (Murgatroyd et al. 2009). Similarly, ELS leads to hypomethylation 
of a key regulatory region of the pituitary Pomc gene promoter, which similarly serves as a 
binding site for Mecp2 (Wu et al. 2014). 
Altogether, studies in rodents and human suggest that early life trauma results in increased 
HPA axis responsiveness to stress in adulthood, partly due to epigenetic programming of 
genes involved in the stress regulation (e.g.; Avp, Pomc). Such epigenetic marks may confer 
an increased risk for the development of psychiatric disorders later in life. These insights 
might also help to identify opportunities to develop new strategies for diagnosis, prevention, 
and successful treatment of stress-related mental disorders. 
 
1.3 Glucocorticoid Receptor (GR) 
GCs are steroid hormones secreted by the adrenal glands. As mentioned above, GCs serve as 
a major mediator of the stress response. Since almost every cell type in the body is sensitive 
to GCs, these hormones regulate also other important processes in the body, such as 
metabolism, inflammation, immunity, and fetal development (Zanchi et al. 2010; Zunszain et 
al. 2011). 
GCs exert their physiological effects through two types of receptors: the glucocorticoid 
receptor (GR) and the mineralocorticoid receptor (MR). In the context of this thesis, I will 
focus only on GR. 
 
1.3.1 Glucocorticoid receptor protein 
GRs are ubiquitously expressed; however the levels of both mRNA and protein differ 
considerably between tissues (Turner et al. 2010). For example, GR can be found at high 
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levels in pituitary corticotropes and throughout the brain, especially in hippocampus and 
hypothalamic neurons (de Kloet et al. 1998).  
The GR belongs to the superfamily of nuclear receptors that act in part as ligand-gated 
transcription factors. Similarly to other steroid receptors (mineralocorticoid receptor, MR; 
estrogen receptor ER; androgen receptor, AR), the GR is composed of 4 main domains ( 
Figure 4): 
ü The N-terminal domain (NTD), containing the ligand-independent transactivation 
domain (AF-1), which is important for the interaction with other unrelated proteins necessary 
for the initiation of transcription; 
ü The DNA-binding domain (DBD), containing two zinc fingers, which controls GR 
binding to specific DNA sequences, termed glucocorticoid response elements (GRE). These 
palindromic motifs locate within the regulatory regions of GR target genes;   
ü The hinge region, containing a nuclear localization signal;  
ü The C-terminal ligand binding domain (LBD), responsible for the binding of GCs and 
ligand-induced activation of GR. The LBD contains also a second, ligand-dependent 
transactivation domain (AF-2), as well as sequences important for receptor dimerization, 
nuclear translocation, and interaction with co-activators (van der Laan et al. 2008; Nicolaides 
et al. 2010; Zanchi et al. 2010).    
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Figure 4: Schematic structure of human GR α 
The GR protein is composed of distinct regions: N-terminal domain (NTD); DNA-binding domain (DBD); hinge 
region (HD); ligand-binding domain (LBD); activation function-1/2 (AF-1/2); nuclear localization signal 1/2 
(NL1/2); and binding sites for heat shock proteins (Hsps). Numbers represent amino acid positions. Adapted 
from (Nicolaides et al. 2010) 
 
 
1.3.2 Glucocorticoid receptor signaling 
In the absence of ligand, GRs reside in the cytoplasm and are associated with a large complex 
of various proteins, including the chaperone heat-shock protein 90 (Hsp90) and the co-
chaperone Fkbp5, which regulate folding, maturation and trafficking of the receptor (Grad et 
al. 2007). Upon binding of the corticosteroid hormone, this complex undergoes 
conformational changes; hereby Fkbp5 is exchanged with Fkbp4, which then recruits dynein. 
This factor allows GR to translocate into the nucleus and to influence expression of its target 
genes by acting as a transcription factor (TF). GRs either directly bind to GREs as a 
homodimer or interact with other TFs as a monomer (Figure 5) (Binder et al. 2008; van der 
Laan et al. 2008). Typically, the GRE sequence consists of 15 nucleotides, containing a pair 
of inverted repeats and is separated by three nucleotides (n). The consensus sequence of the 
GRE is 5' AGAACAnnnTGTTCT 3', but many variations are possible (Del Monaco et al. 
1997). The regulatory regions of GR target genes may contain one or more GREs, as well as 
imperfect GREs or half sites. Importantly, GREs have been identified for both, GR-inducible 
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and GR-repressed genes (positive and negative GREs) (Arteaga et al. 2008; Drouin et al. 
1989; Hubler et al. 2004; Malkoski et al. 1999).  
 
 
 
Figure 5: Molecular mechanism of GR-mediated signalling upon cortisol binding 
In the unbound form the GR resides in the cytoplasm in a complex with Hsp90, p23, and Fkbp5. After ligand 
binding, Fkbp5 is replaced by Fkbp4. Subsequently Hsp90 and p23 detache and the GR translocates to the 
nucleus. Within the nucleus, the GR forms dimers or monomers and binds either to glucocorticoid response 
elements (GREs) or negative glucocorticoid response elements (nGREs) to activate or repress the transcription 
of target genes, respectively. GR monomers can also interact with other TFs to repress gene expression 
irrespectively of DNA binding. Adapted and modified from (van der Laan et al. 2008; Sinclair et al. 2013) 
 
The expression of multiple GR target genes in neuronal tissues was recently investigated on a 
genome-wide scale (Sato et al. 2008; So et al. 2008; Datson et al. 2011). I will discuss here 
several examples of classical GR target genes, which were examined in this thesis. The most 
intensively studied gene is the Fkbp5 gene encoding FK506 binding protein 51. Under resting 
conditions, Fkbp5 is shown to be expressed ubiquitously in the adult mouse brain, with higher 
levels in hippocampus (Scharf et al. 2011). GCs have the ability to strongly increase its 
expression. For example, significant mRNA induction was found in the mouse PVN 4 and 8 h 
following dexamethasone application, which came back to baseline 24 h after injection. 
Changes were found also in response to stress, both after 30 minutes of restrained stress 
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(moderate stressor) and 24 h of food deprivation (strong and long lasting stressor). Thereby, 
induction of  Fkbp5 was much stronger in tissues with low basal expression (e.g.; PVN, 
central amygdala) than in tissues with high basal expression (e.g.; hippocampus)  (Scharf et 
al. 2011). It is important to note that Fkbp5 decreases the affinity of GR for its ligand; 
accordingly high levels of Fkbp5 expression can lead to glucocorticoid resistance. Thus GR-
mediated induction of Fkbp5 mRNA was suggested to correspond with GR sensitivity (Binder 
et al. 2008). The functional GRE (AGAACAgggTGTTCT) maps within intron E (between 
exons 5 and 6) and locates ~ 75 kb distal from the TSS. It is important to mention that this 
GRE is conserved between human, rat, and mouse. The functionality of this site was 
confirmed by different experiments, e.g.; gel shift assays, which demonstrated the interaction 
of the GR with the GRE at intron E, and mutational analysis, which showed abolished 
responsiveness to glucocorticoids. The authors predicted also another hormone binding site, 
which was shown to bind only progesterone receptor, but not GR (Hubler et al. 2004). 
Another well-established GR target gene is Sgk1 (serum- and GC-regulated serine/threonine 
protein kinase) (Sato et al. 2008), which is suggested to be involved in neuronal functions 
(e.g.; long-term memory formation) and the pathophysiology of different neurodegenerative 
brain diseases (e.g. Parkinson’s and Alzheimer’s disease) (Lang et al. 2010). The mouse and 
human Sgk1 gene contain one known GRE, located ~ 1kb upstream of the TSS (So et al. 
2007; Arteaga et al. 2008). Sgk1 is described as an immediate early response gene that is 
rapidly induced by serum and GCs. Increasing doses of dex induce expression of Sgk1 in rat 
hypothalamus. The highest peak of expression was seen 2 h after injection of 2mg/kg dex 
(Sato et al. 2008). In the rat hippocampus Sgk1 mRNA was either strongly induced, as 
measured 60 min after corticosterone challenge ( Sarabdjitsingh et al. 2010) or not regulated 
(van Gemert et al. 2006). 
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The best described function of another GR target gene Dusp1 (Dual-specificity phosphatase 
1) is inactivation of the mitogen-activated protein (MAP) kinase; therefore it may play an 
important role in cellular response to intrinsic and environmental signals. Within the Dusp1 
gene, several GREs has been predicted. These sites are homologues between human and 
mouse, and are located ~1.3, ~4.6, ~24, ~28, ~29 (~27 in mouse) kb upstream of the TSS. The 
study of Tchen et al. (2010) revealedthat in response to dex application, GR occupies its 
response elements 1.3, 4.6 and 24 in human, and 27 and 24 in mouse. 
Gilz (glucocorticoid-induced leucine zipper) is widely expressed in various tissues, including 
brain. It is known to be strongly upregulated in response to GCs in different cell types, where 
Gilz mediates anti-inflammatory and immunosuppressive functions. There are multiple 
predicted GREs within the Gilz gene sequence. It was also demonstrated to be regulated by 
other steroid hormones (So et al. 2007). 
Drr1 (Down-regulated in renal cell carcinoma 1; also known as TU3A and Fam107A) is 
mainly known for its role as a candidate tumor suppressor gene in the development of renal 
cell carcinoma (Ogawa et al. 1992). However, Schmidt et al.(2011), reported recently that 
Drr1 is also expressed in the cerebellum and limbic areas of mouse brain and is significantly 
induced by stress (in pups by 24 h of maternal deprivation and in adult mice by 24 h of food 
deprivation) and dex (effect observed 8 h after injection). Increased Drr1 mRNA was 
observed mainly in the PVN and hippocampal CA3 region. Additionally, Drr1 induction was 
abolished by GR antagonist treatment. In the same study GR was shown to bind to all three 
predicted GREs, located within promoter region, intron 1 and 3’UTR. 
Pdk4 (Pyruvate dehydrogenase kinase 4), similarly to Sgk1, is an immediate early response 
gene (Sato et al. 2008) and its activity contributes to the regulation of glucose metabolism. 
Expression of Pdk4 mRNA is induced by glucocorticoid receptor binding to two distal GREs 
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(Connaughton et al. 2010) and has been shown to be elevated in the neonatal rodent 
hypothalamus after starvation (after 6 hours of maternal deprivation) (Ding et al. 2010). 
 
1.3.3 Structure of the Nr3c1 gene 
The GR is encoded by the Nr3c1 gene (nuclear receptor subfamily 3, group C, member 1), 
which is composed of 9 exons (Figure 6): 8 exons (2-9) comprising the GR protein sequence; 
and multiple untranslated first exons, responsible for the formation of various mRNA 
transcript variants, which encode however the same protein due to splicing to a common 
acceptor site within exon 2. Additional control to avoid translation of 5’ heterogeneity is 
provided by an in-frame TGA stop codon located directly upstream of the ATG start codon 
(Turner et al. 2010). It is important to note, that the structure of the GR promoter is highly 
conserved between human, rat and mouse (Figure 6). For the human GR gene, at least 15 
splice variants, derived from nine untranslated first exons have been published (Breslin et al. 
2001; Presul et al. 2007; Turner et al. 2005), eleven for rat (McCormick et al. 2000) and ten 
for mouse (Bockmühl et al. 2011; Strähle et al. 1992). All identified alternative first exons are 
located either in distal (~32 kb upstream of the TSS) or proximal (~5 kb upstream of the TSS) 
promoter regions (Bockmühl et al. 2011; Breslin et al. 2001; Turner et al. 2005). 
The generation of distinct mRNAs variants potentially influence mRNA processing, mRNA 
stability, and translation efficiency (Bockmühl et al. 2011). Although the GR is ubiquitously 
expressed, differential usage of distinct GR first exon promoters is shown to be responsible 
for its tissue- and cell-type specific expression (Cao-Lei et al. 2011; Turner et al. 2010). For 
example, human 1B and 1C transcripts are reported to be widely expressed in the brain, as 
well as in various peripheral tissues (Alt et al. 2010), (Turner et al. 2005). Other transcript 
variants show more restricted expression patterns: 1D is found mainly in testis, cerebellum, 
thymus (Presul et al. 2007) and hippocampus (Turner et al. 2005);  1A in thymocytes (Presul 
et al. 2007); 1E and 1F in the immune system and hippocampus (Turner et al. 2005). On the 
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other hand, rat 1.7 exon has been suggested to be specific to hippocampus; distally located 1.1 
was detected in thymocytes; while 1.6 and 1.10 are the most abundantly expressed 
(McCormick et al. 2000). However, much less was known about the tissue distribution of 
mouse first exons. 
Moreover, the activity of the different promoters might be affected by DNA methylation, as 
the proximal exons lie within a CpG island (Cao-Lei et al. 2011; Weaver et al. 2004) and 
contain in their sequence putative binding sites for multiple methylation- sensitive 
transcription factors, including Yin Yang 1 (YY1) (Breslin et al. 1998). Altogether, the 
complex regulation of GR expression allows each individual cell and tissue for appropriate 
response to environmental demands and tightly controlled GR levels, as even small changes 
may have significant pathophysiological consequences. 
In addition to the heterogeneity of the GR 5’untranslated region (5’UTR), three different 3’ 
splice variants can be generated (GR-α, GR-β, and GR-P), which differ in their functions. The 
predominant form GRα, which consist of 777 amino acids (aa) in human and 783 aa in mouse, 
is the most active form, which mediates GCs action. The last 50 aa of the C-terminus in GR-α 
are replaced by 15 unrelated aa in the splice variant GR-β, which are encoded by exon 9β. 
This form is unable to bind ligands due to changes in the LBD. GR-β contributes to ~ 1% of 
total GR and is suggested to act as an inhibitor of GR-α. A third variant, GR-P is translated to 
a truncated protein (676 aa), due to the lack of exons 8 and 9. GR-P has a disrupted LBD and 
is also unable to bind corticosteroids (Alt et al. 2010; Zanchi et al. 2010).	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Figure 6: Schematic Nr3c1 gene structure. 
The upper part of the panel represents multiple untranslated first exons (in red), and their homology between 
human, rat, and mouse. Exons 1A and 1I in human; 1.1 in rat and mouse are located in the distal promoter (~32 
kb upstream of the TSS), outside of the CpG island. Exons 1D-1H in human, 1.4-1.11 in rat, and 1.3-1.12 in 
mouse are located within the proximal GR promoter (~5 kb upstream of the TSS). The lower part of the panel 
represents exons 2-9 (in violet) which are transcribed to the GR protein. Three different splice variants can be 
formed: GR-α, containing exons 2-9α; GR-β, containing exons 2-9β; GR-P, containing exons 2-7. The 
3’untranslated regions (3’UTR) are shown in orange. Note, the size of the exons is not shown on scale. 
a (Breslin et al. 2001; Presul et al. 2007; Turner et al. 2005); b (McCormick et al. 2000), 
c (Bockmühl et al. 2011; Strähle et al. 1992). Adopted and modified from (Bockmühl et al. 2011) 
 
1.3.4 Epigenetic programming of GR 
Accruing evidence supports a role of epigenetic programming in the regulation of 
glucocorticoid receptors. Most of the studies are focused on the methylation pattern upstream 
of rat exon 1.7 and its human orthologue 1F (see Figure 6), which contain a potential binding 
site for nerve growth factor- inducible protein A (NGFI-A, also called KROX, EGR1, or 
ZIF286). Indeed, the study of Weaver et al. (2004) identified a critical change in DNA 
methylation at the promoter region of the GR gene in response to variations in maternal care 
behaviour (in adult Long-Evans rat offspring of high- versus low LG-ABN mothers). The 
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authors have shown a reduced methylation of 5’CpGs at the binding site for the transcription 
factor NGFI-A at the promoter 1.7 in the hippocampus. This TF preferentially binds to 
unmethylated DNA and increases GR gene expression. Pups raised by high LG-ABN mothers 
show thus more efficient binding of NGFI-A, higher GR 1.7 transcript expression, and total 
GR protein in the hippocampus. In contrast, offspring receiving less maternal care, display 
higher CpG methylation, less NGFI-A binding and consequently reduced GR expression. 
These events correlated with decreased HPA-axis feedback efficiency and an increased 
emotional response to stress (Weaver et al. 2004). Subsequent human post-mortem studies 
identified site-specific increases in the methylation of human exon 1F in suicide completers 
with a history of childhood abuse (in comparison to suicide victims with no history of abuse 
and control subjects). These changes were accompanied by altered NGFI-A binding, and 
decreased expression of the GR 1F transcript as well as total GR protein (McGowan et al. 
2009). It is important to note that epigenetic changes caused by early life stress do not appear 
to be restricted to brain tissues, but can be also detected in peripheral tissues, e.g.; a history of 
childhood adversity is associated with increased cytosine methylation at the NGFI-A binding 
site at exon 1F in leukocytes of healthy adults and associates with an attenuated cortisol 
response to the dex/CRH test (Tyrka et al. 2012). Similarly, subtle increases in the 
methylation at this specific site in response to prenatal stress was measured in umbilical cord 
blood of newborns (Oberlander et al. 2008) and blood cells of adolescent children (Radtke et 
al. 2011). These findings suggest that early-life stress may result in epigenetic marking of 
specific CpGs within the GR promoter, which lead to changes in glucocorticoid receptor 
transcription in humans and rats, and consequently altered regulation of HPA-axis activity and 
stress responsiveness.  
The existence of additional binding sites for various TFs located within the CpG island 
suggests the potential control of GR expression by other promoters than 1.7 (1F) in a 
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methylation-dependent manner. In fact, some findings reported changes in expression and/or 
methylation of additional alternative GR first exons. Labonte et al. (2012) observed, in 
hippocampal tissues of suicide victims with a history of ELS, differential methylation within 
exons 1B, 1C, and 1H and their reduced transcription. These changes contributed to a 
decreased level of total GR mRNA (Labonte et al. 2012). Hypomethylation of the 1.10 
promoter and an increased total level of GR was also observed in the liver of offspring of 
Wistar rats fed with protein-restricted diet during pregnancy (Lillycrop et al. 2007). Recently, 
McGowan et al (2009), reported that among the offspring of high LG-ABN mothers, in 
addition to the previously described elevated levels of the 1.7 splice variant, also others ones 
known to be expressed in the hippocampus (i.e.; 1.5, 1.6, 1.10, and 1.11) showed an increased 
transcription. These may suggest that Nr3c1 gene regulation is based on the coordinated 
regulation of various splice variants, rather than single ones (McGowan et al. 2011). 
Recently, our studies have shown that ELS leads to up-regulation of the GR mRNA in the 
hypothalamic PVN of adult male mice with a history of ELS. This finding is correlated with 
an increased site-specific DNA methylation of a single CpG dinucleotide (termed here CpG3) 
located upstream of the CGI, within the so-called “CpG island shore”. Importantly, ELS-
mediated epigenetic programming of GR appears to be highly tissue-specific and is observed 
exclusively in the hypothalamic PVN, but not at other sites involved in GR-mediated negative 
feedback, e.g.; hippocampus and pituitary (Bockmühl et al. submitted). 
Computational analysis predicted the residue CpG3 to be part of a binding site for the 
ubiquitously expressed zinc finger transcription factor Yin Yang 1 (YY1) (Bockmühl et al. 
submitted). The name Yin Yang 1 reflects the multifunctional nature of this factor to act as a 
transcriptional activator, repressor, or initiator of transcription, depending on cellular context 
and the availability of additional regulatory factors (Shi, Lee, and Galvin 1997). The predicted 
binding site at the antisense strand (5’-CGCCATCTT-3’), strongly resembles the consensus 
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sequence 5'-(C/g/a)(G/t)(C/t/a)CATN(T/a)(T/g/c)-3' (Hyde-DeRuyscher, Jennings, and Shenk 
1995) and is homologues to a previously identified distal YY1 binding site (dYY1) within the 
human GR (Breslin et al. 1998). By a series of in vitro and in vivo studies, we showed YY1 to 
occupy its distal binding site within the mouse GR promoter. As YY1 binding is methylation-
sensitive (Kim et al. 2003), methylation of the CpG3 site in the PVN of ELS mice abolishes 
its binding and allows for enhanced GR promoter activity, resulting in up-regulated GR 
mRNA (Bockmühl et. al. submitted).  
 
	  
	  
Figure 7: Summary of finding Y. Bockmühl et al. submitted 
In hypothalamic PVN, site-specific CpG methylation, due to maternal separation during the first 10 days of life, prev:ents 
binding of the transcriptional repressor YY1, thus allowing for enhanced GR promoter activity, resulting in elevated GR 
protein levels. On the other hand, control mice exhibit lower methylation levels. As a result, YY1 can bind and repress GR 
promoter activity.   
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1.4 Aim of the thesis 
	  
Numerous studies in human have shown that adverse events experienced in early life are 
important risk factors for the development of stress-related psychiatric disorders, including 
anxiety and MDD.  Previous work from our laboratory has shown that male C57BL/6N mice 
exposed to early-life stress (ELS) display distinct neuroendocrine and behavioural 
abnormalities in adulthood important to MDD. This phenotype is accompanied by enduring 
epigenetic programming of genes involved in hypothalamic-pituitary adrenal (HPA) axis 
regulation: arginine vasopressin (Avp) (Murgatroyd et al. 2009) and pro-opiomelanocortin 
(Pomc) (Y. Wu et al. 2014). These results raised the question, whether the Nr3c1 gene, which 
encodes the glucocorticoid receptor (a major negative feedback regulator of the stress axis), is 
also epigenetically programmed by ELS in mice.  
 
The aims of the work presented here were: 
ü to investigate the tissue distribution of newly identified GR alternative first exons and 
their regulation by different signaling pathways in ELS-naïve mice [work done jointly with 
Yvonne Bockmühl (Bockmühl et al. 2011)]; 
ü to investigate regulation of GR first exons by ELS [work done jointly with Yvonne 
Bockmühl (Bockmühl et al. submitted]; 
ü to assess the biological activity of enhanced GR expression in the PVN, by measuring 
the transcriptional regulation of classical downstream GR target gene; 
ü to analyse the methylation pattern of a YY1 DNA binding site located within the CpG 
island shore region of the GR promoter in CD1 mice and human tissues. 
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2.1 Animals 
C57BL/6N and CD1 mice were housed under standard laboratory conditions, with 12-h daily 
illumination (lights on at 6:00) at the animal facility of the Max-Planck Institute of Psychiatry. 
Time-pregnant C57BL/6N females were purchased from Charles River, Sulzfeld, Germany. 
All procedures were approved by the Regierung von Oberbayern and were in accordance with 
European Union Directive 86/609/EEC 
 
2.1.1 Maternal separation procedure 1 
The maternal separation (MS) procedure was used to induce early-life stress (ELS) in 
C57BL/6N mice. The day of pup’s birth was considered as postnatal day 0 (PND 0). In the 
ELS group, pups were physically separated from their mothers (3 h daily, starting from PND 
1 to PND 10) by placing them, as individual litters, to a clean temperature-controlled (heating 
pad) cage. After 3 hours of separation, pups were transferred back in the maternal nest.  In the 
control group, animals were left undisturbed and remained in their home cages during the 
whole experiment. In both experimental groups, pups were kept with their mothers until 
weaning (PND 21) and were thereafter housed in sex-matched groups (~5 mice per cage). 
Only males were used for the following experiments (DNA methylation and mRNA 
expression analyses, in vivo ChIP experiments, and endocrine analysis).   
 
2.1.2 Corticosterone treatment 2 
The first cohort (used for quantitative RT-PCR) of 10 weeks old male mice (control and ELS) 
was injected intraperitoneally at 8 a.m. either with saline with cyclodextrin (vehicle) or 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 ELS was performed by employees of the animal facilities of the MPI of Psychiatry, under the supervision of 
Dr. Alexandre Patchev and Prof. Dr. Osborne Almeida	  
2 CORT injection was performed by Dr. Alexandre Patchev	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corticosterone complexed in 25% cyclodextrin (3 different doses: 0.1; 1.0; 10.0  mg per kg of 
body weight). Animals were sacrificed 3 h after injection. The second cohort (used for ISH 
and ChIP) was injected intraperitoneally either with saline or only one dose of corticosterone 
(1.0 mg per kg of body weight). Animals were sacrificed 90 min after injection. Brains from 
both cohorts were collected and preceded as described in the next section. 
 
2.1.3 Tissue preparation 
Male C57BL/6N mice were sacrificed at three time points (10 days, 6 weeks, and 3 months) 
by cervical dislocation. Brain tissues were collected and immediately snap-frozen by 
immersion in cold iso-pentane and stored at -80°C. For IHC assay brains of 3 month old mice 
were fixed with PFA through cardiac perfusion, fixed in 4% PFA overnight, sucrose 
cryopreserved (15 % and 30%), snap-frozen by immersion in cold iso-pentane and stored in -
80°C. Brains were next cryosectioned (10 µm thickness) and stained with cresyl violet to 
verify anatomical precision. Paxinos mouse stereotaxic brain atlas was used as a reference for 
histological control (Franklin and Paxinos 2008). Sections containing the region of interest 
(PVN: bregma −0.75 to −0.85; hippocampus: bregma −1,70 to −1,90) were mounted on 
Superfrost glass slides, stored at -20°C and used for immunohistochemistry and in situ 
hybridisation. In addition, tissue punches (0.8 mm diameter) were taken from brain areas 
containing PVN and dentate gyrus and frozen at -80°C for further analysis.  
 
2.2 Human samples 
2.2.1 Collection of peripheral blood cells and buccal swabs 
Human peripheral blood cells and buccal swabs were obtained from healthy male volunteers, 
age 27-60 years for subsequent DNA extraction and methylation analysis.  
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2.2.2 Post mortem brain samples 3 
Human post mortem brain samples (inferior cortex, hippocampus, and hypothalamus) were 
gifted by the Brain Bank Center Munich (Zentrum für Neuropathologie und Prionforschung). 
For our analysis we obtained tissues from males aged 35-65 years (the cause of death was not 
related to a brain disease). Appropriate areas of interest were identified by histological control 
(staining with cresyl violet), punched, and frozen at -80°C for further bisulphite sequencing 
analysis. 
 
2.3 RNA analysis  
2.3.1 RNA isolation 
Total RNA from snap frozen brain tissues was isolated using a previously described protocol 
for simultaneously extracting DNA and RNA from tiny neuroanatomically-defined brain 
regions (Bettscheider, Murgatroyd, and Spengler 2011). Briefly, samples were homogenised 
at RT by vortexing in 400 µl of guanidinium thiocyanate (GTC) buffer (4.5 M guanidinium 
thiocyanate; 2% N-Lauroylsarcosine; 50 mM EDTA pH 8; 25 mM Tris-HCl pH 7.5; 0.1 M 
beta-mercaptoethanol; 0.2% antifoam A) and passing several times through a syringe needle. 
Each sample was then splited into two equal parts (200 µl each), the first one for RNA and the 
second one for DNA extraction. The total volume of the homogenate was used only when 
processing with one type of nucleic acid was required. For RNA purification, 1/10 volume of 
NaOAc, 1 volume of acidic phenol and 1/2 volume of chloroform:isoamyl (24:1) was added. 
Each sample was vortexted, incubated on ice for 10 min and centrifuged for 20 min at 13.000 
rpm at 4 °C. The RNA in upper aqueous phase was then transferred to a new tube, 
precipitated with an equal volume of 70% EtOH and further processed according to the 
manufacturer’s instructions (Nucleospin RNA II kit, Macherey Nagel). RNA was eluted in 25 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 The appropriate areas were dissected out under the guidance of  Dr. med. Thomas Arzberger	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µl of RNase-free water and the concentration was measured spectrophotometrically with a 
NanoDrop photometer. 
 
2.3.2 cDNA synthesis (reverse transcription) 
For cDNA synthesis, 200 ng of RNA was reverse-transcribed using the RevertAid Premium 
ReverseTranscriptase (Fermentas) and oligo(dT) primers. The reaction was performed 
according to the manufacturer’s instructions. 
 
2.3.3 Quantitative PCR analysis 
Expression levels of genes of interest were determined by using the LightCycler 2.0 
Instrument (Roche, Mannheim, Germany) and LightCycler FastStart DNA Master plus SYBR 
GreenI Kit (Roche). DNA amounts precipitated during chromatin immunoprecipitation were 
analysed using the MJ Mini Opticon light cycler (Bio-Rad) and the Absolute Blue QPCR 
Sybr green mix (ABgene). All experiments were performed according to the manufacturer’s 
protocols.  Threshold and noise band were set in all compared runs to the same level. qPCR 
results were determined by the 2–ΔCt method (Livak et al. 2001) using the PCR efficiency. 
Relative expression of analysed genes was normalized to the expression of the house keeping 
gene Atp5j. Fold enrichment of ChIP samples was normalized relative to values of control 
samples. The primers used for qRT-PCR are listed in Table 1 and 3. 
 
2.4 DNA analysis  
2.4.1 Genomic DNA isolation 
For genomic DNA purification from the snap frozen brain tissues, the second half of the 
homogenate (as described in section 2.3.1 “RNA isolation”) was used. To each tube equal 
volumes of lysis (AL) buffer and 100% EtOH were added and loaded on a Spin Column 
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(DNeasy Blood and Tissue Kit, Qiagen). Washing steps were performed according to the 
manufacturer’s protocol and the DNA was eluted with 70°C warm elution (AE) buffer. 
Genomic DNA from human peripheral blood and buccal swabs was extracted using the 
QIAmp DNA mini kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions. 
 
2.4.2 PCR reaction /Colony-PCR 
Standard PCR reactions were performed using the Taq DNA Polymerase Kit (Fermentas). 
The PCR reaction mix was prepared in a total volume of 25 µl in the presence of 2 µl of DNA 
template, 1x Taq Buffer with (NH4)2SO4; 2.5-3.0 mM MgCl2; 0.6 mM dNTP; 0.4 µM 
forward and reverse primer and 0.04 u/µl Taq polymerase final concentration. Standard 
amplification conditions are: 
 
1 cycle 6 min 95°C 
45−50 cycle 1 min 95 °C, 1 min at optimal annealing temperature, 1 min 72 °C 
1 cycle 5 min 72 °C 
 
For colony PCR a small amount of a bacterial colony was picked from an agar plate and 
added to the PCR reaction mixture containing T7- and SP6-primers (Sigma, Steinheim, 
Germany). Clones were amplified using the following conditions: 
 
1 cycle 4 min at 95°C 
10 cycles 30 s at 94°C, 30 s at 56°C and 30 s at 72°C 
30 cycles 30 s at 94°C, 30 s at 48°C and 30 s at 72°C 
1 cycle 5 min at 72° C 
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2.4.3 Bisulfite sequencing 
Sodium bisulfite conversion was performed with 400 ng of genomic DNA using the EpiTect 
Bisulfite Kit (Qiagen) according to the manufacturer’s instructions. This chemical reaction 
leads to the conversion of non-methylated cytosines to uracils. After PCR amplification with 
primers specific to bisulfite converted DNA, products were purified (NucleoFast PCR 
Cleanup Plate, Macherey-Nagel) and ligated overnight at 4°C into pGEM-T vectors. Purified 
ligation products were used for transformation with electrocompetent DH5α bacteria. After 
overnight incubation at 37°C with blue/white selection, positive clones were amplified. 
Colony PCR reactions containing the expected amplicons were cleaned up using a 
commercially available kit (Machery Nagel Nucleofast) and subjected to the Big-Dye 
sequencing reaction. 
 
2.4.4 Big Dye terminator reaction and sequencing 
3 µl/well of master mix for Big-Dye reaction: 0.2 µM sequencing primer (usually T7, but also 
SP6 or T3), 1x Sequencing Buffer and Ready Reaction Mix of the BigDye Terminator v3.1 
Cycle Sequencing Kit (Applied Biosystems, Darmstadt, Germany) was dispensed into a 96-
well plate and mixed with 2 µl of cleaned up colony PCR product or 0.5-2.0 µl purified 
vector. The reaction was proceeded on a thermocycler with the following parameters:  
 
1 cycle 1 min at 96°C 
35 cycles 10 s at 96°C, 5 s at 50°C and 4 min at 60°C 
 
After a clean-up step (Millipore Montage 96 Sequencing Clean-Up Kit) products were 
processed on a capillary sequencer (ABI 3100 DNA). For bisulfite sequencing ~24 
independent recombinant clones per amplicon were analysed. 
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2.4.5 Chromatin immunoprecipitation (ChIP) assay 
In vivo chromatin immunoprecipitation assays were performed as described previously 
(Murgatroyd et al. 2009). Frozen tissue punches were resuspended into 150 µl of ice-cold 
PBS supplemented with 1x protease inhibitor cocktail (PIC) (Sigma Aldrich) and then passed 
several times through a syringe needle. After a centrifugation step (4.000 rpm/ 5 min/ 4°C), 
150 µl  of PBS containing PIC was added to the pellet. Samples were then incubated for 15 
min at RT on a rotation platform in the presence of formaldehyde (final concentration 1%) to 
cross-link proteins with DNA. The reaction was stopped by adding glycine (final 
concentration 125 mM) and samples were incubated with rotation for additional 5 min. 
Samples were washed twice with 150 µl PBS containing PIC by successive centrifugation 
steps (4000 rpm/ 5 min/ 4°C) and the pellet was resuspended in cell lysis buffer (with protease 
inhibitor). After incubation for 10 minutes on ice samples were resuspended in nuclear lysis 
buffer and sonicated 3 times for 3-4 min (30 seconds "ON" / 30 seconds "OFF") with the 
Bioruptor TM (Diagenode, Liege, Belgium) in an ice-water bath. The DNA concentration in 
the sheared chromatin was determined with a SmartSpec Plus spectrophotometer (Bio-Rad) 
and aliquots (OD260nm = 0.8) were then subjected to immunoprecipitation using an antibody 
specific to GR (rabbit polyclonal anti-GR H300X in dilution 1:100; Santa Cruz). To reduce 
unspecific binding during immunoprecipitation, antibodies were pre-incubated with sheared 
chromatin DNA on a rotating platform at 12°C overnight, while Dynabeads Protein G 
(Invitrogen) were added on the following day and incubated for another hour at 12°C on a 
rotating platform. Washing of the Protein G bead-antibody/chromatin complex was performed 
as described in the Upstate Magna ChIP G protocol, but for 7-10 min per wash-buffer. After 
reversecrosslinking, protein digestion, and DNA isolation using the UltraClean PCR Clean-
Up Kit (Mobio), fragments were dissolved in 100 µl TE buffer and subjected to real-time 
PCR. 
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2.4.6 Ligation 
Purified PCR products were ligated overnight at 4°C into pGEM-T vector using the pGEM-T 
Easy Vector System (Promega) according to the manufacturer’s protocol.  After ligation, 
products were precipitated by adding 1 μl glycogen, 0.1 volume  NaAc (3M) and 2.5 volumes 
of pure ethanol to the ligation mix and placed in liquid nitrogen for 1 min. Samples were then 
centrifuged (4°C, 12.000 rpm, 20 min), and the pellet was washed with 70% ethanol prior to 
another centrifugation step (4°C, 12.000 rpm, 10 min), air dried and dissolved in 5 µl di-
distilled water (ddH2O). 
 
2.4.7 Transformation into electrocompetent bacteria 
Aliquots (40 µl) of electrocompetent DH5α bacteria were thawed on ice and diluted in 100 µl 
of ice-cold water. 45 µl of diluted bacteria was mixed with 5 µl of cleaned up ligation product 
or 0.5 µl plasmid-DNA (~1 µg/µl) and incubated 1 min on ice. The mixture was then 
transferred to a pre-cooled Gene Pulser Cuvette (width 0.1 cm; Biorad) and 
electrotransformed (settings were 1.5 kV, 200Ω, 25 µF). Immediately after electroporation, 1 
ml of SOB medium (20 g/l tryptone; 5 g/l yeast extract; 10 mM NaCl; 2.5 mM KCl) was 
added to the bacteria and incubated for 1 h at 37°C. 50-200 µl of the suspension was spread 
out on an agar plate containing ampicillin (50 µg/ml) and coated with 200 µl of indicator 
solution [a mixture of 105 µl ddH2O, 40 µl DMSO, 30 µl IPTG (0.1 M) and 25 µl X-gal (20 
mg/ml)] and incubated overnight at 37°C. 
 
2.4.8 Blue/white screening 
The pGEM-T vector contains multiple cloning sites within the LacZ gene coding for β-
galactosidase. The functional enzyme is activated in the presence of IPTG (isopropyl-[beta]-
D-thiogalactopyranoside) and converts the substrate X-Gal (5-bromo-4-chloro-3-indolyl-
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[beta]-D-galactopyranoside) into a bright blue product. Successful cloning of an insert 
disrupts the coding sequence of LacZ. Thus, bacteria harbouring the recombinant plasmid 
form white colonies. In the absence of an insert, bacterial colonies stain blue. Colony PCR 
from single positive clones was conducted and the expected size of inserts was verified by 
agarose gel electrophoresis. 
 
2.5 Plasmid preparations 
2.5.1 Generation of plasmid constructs used as standards for qRT-PCR 
pGl3-Control-T7: Two phosphorylated oligonucleotides containing the T7 promoter 
sequence (see Annex I) were annealed to generate an oligonucleotide with a 5’-HindIII and 
3’-NcoI overhang and a nested HindIII restriction site at the 3’end (the 5’-HindIII overhang is 
not reconstituted after ligation). The annealed oligonucleotide was cloned into a HindIII/NcoI 
digested pGl3-Control vector (Promega). 
pGl3-Control-T7-exon 1 vectors: The DNA fragments coding for alternative GR-exon first 
variants were PCR amplified from cDNA using forward primers specific for each transcript 
and containing a HindIII restriction site, with the a common reverse primer directed against 
exon 2 containing an NcoI restriction site (Ex2R-NcoI). Primers used for this reaction are 
listed in Table 2. The PCR product was cloned into pGl3-Control-T7 vector and its correct 
sequence was verified by sequencing.  
pCR2.1-exon2: The sequence for GR exon 2 containing the target region for qRT-PCR 
reverse primer (Table 1) was PCR amplified using Ex2 primers (Tabble 2).  PCR product was 
cloned into pCR2.1 vector (Invitrogen), and verified by sequencing. 
pCR2.1-exon2-1: pCR2.1-exon2 was digested by HindIII and SspI restriction enzymes and 
ligated with HindIII-SspI exon 1-fragments derived from pGl3-Control-T7-exon 1 vectors.	  
The cloning product pCR2.1-exon2-1 serves as external standard for exon 1 transcript 
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quantification. qRT- PCR standard for total GR was obtained by TOPO TA Cloning the PCR 
product that was amplified by total GR primers (Table 1) into pCR2.1 vector. 
 
2.5.2 Plasmid DNA: mini-preparations 
A single growing bacterial colony was picked from an agar plate and incubated in 2.0 ml SOB 
medium (20 g/l tryptone; 5 g/l yeast extract; 10 mM NaCl; 2.5 mM KCl) supplemented with 
ampicillin (200 µg/ml). A culture was grown overnight at 37°C with vigorous shaking. The 
suspension was transferred to a 1.5 ml Eppendorf tube and centrifuged (14.000 rpm/ 1 min/ 
RT) to pellet the bacteria. Plasmid DNA was isolated using the peqGOLD Plasmid Miniprep 
Kit I (Peqlab) according to the manufacturer’s instructions. To identify positive clones 0.5 µl 
of purified plasmids was used for restriction analysis and additional 0.5 µl for sequencing. 
 
2.5.3 Plasmid DNA: maxi-preparations 
An aliquot (2 ml) of an overnight bacterial preculture was used to inoculate the main culture 
containing 40 ml of TB medium (12 g/l tryptone; 24 g/l yeast extract; 0.4% (v/v) glycerol; 2.3 
g/l KH2PO4; 16.4 g/l K2HPO4·3H2O) supplemented with ampicillin (200 µg/ml) in a 500 ml 
flask After overnight incubation at 37°C with vigorous shaking plasmid DNA was isolated 
and purified according to the NucleoBond PC100 (Machery Nagel, Düren, Germany) kit 
according to the manufacturer’s protocol. After precipitation of the eluate with isopropanol, 
the pellet was dissolved in 400 µl ddH2O and further purified by a phenol/chloroform 
extraction. 
 
2.5.4 Phenol/chloroform extraction of plasmid DNA 
One volume of TE-saturated phenol/chloroform/isoamylalcohol (25:24:1) (pH 8.0) was added 
to the DNA solution. Samples were vortexed for 30 seconds and then centrifuged at 14.000 
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rpm for 1 minute. The aqueous phase (upper layer) was transferred into a new 1.5 ml tube, 
mixed with one volume of chloroform/isoamylalcohol (24:1) and centrifuged again. The DNA 
from the aqueous phase (upper layer) was transferred into a new 1.5 ml tube and precipitated. 
The pellet was dissolved in 40-200 µl TE buffer. The DNA concentration was determined 
with the Smart spec Plus Spectrophotometer (Biorad).  
 
2.5.5 Restriction digest of plasmid DNA 
0.2 to 25 µg plasmid DNA were cleaved by restriction endonucleases (Fermentas, St. Leon-
Rot, Germany or New England Biolabs, Frankfurt am Main, Germany) at selected restriction 
sites in 10 µl to 100 µl reaction volume to obtain specific DNA fragments. Buffers were 
chosen according to manufacturer’s recommendations. Vector backbones were 
phosphorylated when necessary. Reactions were carried out at the recommended temperature 
and incubations lasted 1-16 h. 
 
2.5.6 Blunting of vectors and inserts 
3-5 µg of linearized vectors or inserts were blunted by adding 2 µl dNTPs (2 mM) and 1 µl T4 
DNA Polymerase (Fermentas) to a total volume of 50 µl. The reaction was incubated for 5 
min at RT and inactivated for 20 min at 70°C. 
 
2.5.7 Absolute quantification of exon 1 transcripts 
Vectors containing fragments coding for alternative GR-exon first variants were linearized by 
HindIII (Thermo scientific) digestion and the DNA concentration was measured with a 
NanoPhotometer. Finally the plasmids were serially diluted (1:10) to serve as an external 
homologous DNA standard of known copy numbers. Plasmid concentrations of 10-5 to 10-10 
µg/µl were used, within the range of the cDNA samples, to provide calibration curves for 
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each exon first transcript. Copy numbers of each exon 1 transcript were extrapolated from the 
calibration curve. Molecules per gram plasmid standard were calculated using the formula: 
NA x MW-1; NA = Avogadro constant, MW = molecular weight of plasmid.  
 
2.6 Immunohistochemistry  
Frozen brain sections were allowed to warm-up slowly at RT for 30 minutes, fixed with pre-
warmed 4% paraformaldehyde in PBS containing 2% sucrose for 5 minutes at 37°C and 
rinsed with PBS. Sections were incubated for 2 hours with blocking solution (5% BSA, 5% 
normal goat serum, 0.05% Triton X-100, 50 mM Tris-HCl, 50 mM NaCl, pH 7.4); next 
incubated with the primary antibodies diluted in blocking solution in a humidifying chamber 
for 16 h at 12°C. Sections were then washed three times with PBS for 10 minutes and 
incubated at RT for 2 h with secondary antibodies diluted in blocking solution (1/1000). 
Sections were washed with PBS three times for 10 minutes prior to addition of 4,6-Diamidin-
2-phenylindol (DAPI) diluted in PBS (1/6000) for 5 minutes. Finally, sections were washed 
with PBS three times for 10 minutes before mounting in Mowiol on SuperFrost microscope 
slides. Confocal images were taken using an Olympus laser scanning confocal microscope.  
 
2.7 Cell culture 
SK-N-MC (ATCC no. HTB-10), Be(2)-M17(ATCC no. CRL-226), SHS-Y5Y (ATCC no. 
CRL-226) , AtT-20 (ATCC no.CCL-89), N1E-115, HW3.5 (Baj et al. 2005) and N6 cells 
were grown in Dulbecco's Modified Eagle Medium (DMEM, catalogue no. 41965-062, 
Invitrogen) supplemented with 10% fetal bovine serum (Invitrogen) and 
penicillin/streptomycin. Cells were seeded onto cell culture dishes, one day prior to any 
manipulation, at densities of approximately 1-2 x 104 cells per cm2. 
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2.7.1 bFGF treatment 
AtT-20 cells were maintained in DMEM without phenol red (catalogue no. 31053-044, 
Invitrogen) containing 10% charcoal-treated serum before treatment with bFGF (20 ng/ml; 
catalogue no. 450-33 Peprotech, Hamburg, Germany) for 24 h. Serum was depleted of 
steroids by overnight incubation with active charcoal and subsequent filtration. 
 
2.7.2 Potassium-induced depolarization 
Depolarization experiments in N6 cells were carried out by adding KCl at a final 
concentration of 50 mM to the medium and incubated for 30 min or 2 h.  
 
2.8 Statistical analysis 
Statistical analyses were performed by using t-test or two- way ANOVA, and Newman–Keuls 
test as post hoc test, if appropriate. Data are presented as mean ± SEM. Significance levels 
were set at p<0.05 and a trend was recognized at p<0.1. For calculations SigmaPlot software 
was used. 
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2.9 Primer sequences and antibodies 
 
Table 1:  Expression analysis 
Gene/ 
transcript 
Sequence (5’- 3’) Exons 
Product 
size 
[bp] 
Annealing 
Temp. 
[°C] 
Total GR 
fwd: caagggtctggagaggacaa 
rev: tacagcttccacacgtcagc 
2/3 220 61 
exon1.1 fwd: gttcccatcgcagcctgatcat 1 238 63 
exon1.3 fwd: gtggcgtcactgctctttacca 1 229 60 
exon1.4c fwd: aaggagaggtcaggagtttgg 1 173 61 
exon1.5 fwd: cagctcgctaagagggttttgcattc 1 198 61 
exon1.6 fwd: gacctggcagcacgcgagtc 1 188 64 
exon1.7 fwd: ccagggagaagagaaactaaagaaact 1 200 64 
exon1.9 fwd: cggagtcagtgcctggag 1 209 61 
exon1.10 
fwd: ggcgactgttgacttccttc 
rev: ggagctaaggattctttggag 
1/2 156 61 
exon1.11 fwd: ggctcgctgcctgcagcccagacttc 1 229 61 
exon1.12 fwd: gaattgcggccttaccact 1 186 63 
exon 2 rev: gtgaagacgcagaaaccttgactgtag 2  60-64 
Atp5j 
fwd: tattggcccagagtatcagca 
rev: ggggtttgtcgatgacttcaaat 
3/4 134 60 
Uros 
fwd: tctgaaagacagatggaatgcc 
rev: ccacacggaaagagaagaggc 
3/5,6 174 60 
Avp 
fwd: tcgccaggatgctcaacac 
rev: ttggtccgaagcagcgtc 
1/2 173 56 
Fkbp5 
fwd: gggtgtacgccaacatgttc 
rev:  gaggagggccgagttcatt 
13/14 199 63 
Sgk1 
fwd: cttctggactaatgatgatgcagc 
rev: tgccctttccgatcactttc 
2/3 268 59 
Dusp1 
 
fwd: gagctgtgcagcaaacagtc 
rev: cttccgagaagcgtgatagg 
2/3 177 62 
Gilz 
 
fwd: gataacagtgcctccggag 
rev:  gggatggaggagtgaagac 
1/2 246 62 
Drr1 
(Fam107a) 
fwd: caccgtgagctgcttatgaac 
rev: tcccggactttgatgaactc 
3/5 245 60 
Pdk4 
fwd: cctttggctggttttggtta 
rev: cctgcttgggatacaccagt 
9,10/11 255 64 
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Table 2: Primers for cloning 
Gene/ 
transcript Sequence (5’- 3’) Comment 
HindIII-1.1 fwd: agagaagcttcctctcgtgcatgatgcaacacctg primer to amplify exon 1.1 
HindIII -1.3 fwd: agagaagcttaaagagcacctctgccaaaatgg primer to amplify exon 1.3 
HindIII-1.4c fwd: d agagaagcttcctcagctccgatcagaagtg primer to amplify exon 1.4c 
HindIII-1.5 fwd: agagaagcttcaacttactattccgtctgcaacttg primer to amplify exon 1.5 
HindIII-1.7 fwd: agagaagcttccgagcggttccaagccg primer to amplify exon 1.7 
HindIII-1.9 fwd: agagaagcttccctcgctcggtcccgctcg primer to amplify exon 1.9 
HindIII-1.10 fwd: agagaagcttagaacgcgcgcggggagacg primer to amplify exon 1.10 
HindIII-1.11 fwd: agagaagcttatccctggcccagcgcgctgc primer to amplify exon 1.11 
HindIII-1.12a fwd: agagaagcttacatttctcccttcacctcgcac primer to amplify exon 1.12a 
Ex2R-NcoI rev: gactccaaagaatccttagctcccatggagag Common primer to amplify exon 1 
Ex2 
fwd:  actaatcggatcagagataatgtgg 
rev: agaggatcctctgctgcttggaatctg 
 
T7 
s: agctaatacgactcactatagggaagcttc 
as: catggaagcttccctatagtgagtcgtatt 
 
 
Table 3: Methylation analysis 
Gene/ 
transcript 
Sequence (5’- 3’) 
Product 
size 
[bp] 
Annealing 
Temp. 
[°C] 
Mouse GR (CpG1-9) 
fwd: ttttttttttggagaaggaggtt 
rev: taaaaaatataaaaactacccaatatatc 
193 51 
Human GR (CpG1-11) 
fwd: ttagttgatttgtgttaagggat 
rev: ataaactttcaacaaacctctta 
257 54 
 
Table 4:  ChIP assay 
Gene/ 
transcript 
Sequence (5’- 3’) 
Product 
size 
[bp] 
Annealing 
Temp. 
[°C] 
Fkbp5 
fwd: gttcagctgtgcaatccaga 
rev: agggtgttctgtgctcttcaa 
134 62 
Sgk1 
fwd: acctcctcacgtgttcttgg 
rev: ggtatgagggggtcaggaat 
187 63 
Dusp1 (-27 kb) 
 
fwd: agaagagacccactcaggcc 
rev: ctgggtccactttcccacta 
109 62 
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Table 5: Antibodies 
Antibody Application (dilution) Company 
GR (H300 X) 
ChIP (1:100) 
IHC (1:1000) 
SantaCruz Biotechnology 
Avp (PS 41) IHC (1:100) 
H. Gainer (Ben-Barak et al. 
1985) 
Crh IHC (5:100) Bachem, Torrance, CA, USA 
 
Primary antibodies were visualized using the appropriate secondary antibodies conjugated to 
Dylight 488, Dylight 594 (1:500, Diagenode, 715-485-150, 711-585-152), Alexa 647 (1:500, 
Dianova, Hamburg, Germany, 706-605-148), and IgG-Peroxidase (1:2000, Sigma-Aldrich, 
A6782,A0545
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3.1 Alternative first exon transcripts of the mouse Nr3c1 gene 
 
Work done as part of a publication:  
“Differential regulation and function of 5’-Untranslated GR-exon 1 transcripts” Bockmühl Y, 
Murgatroyd C, Kuczynska A, Adcock M, Almeida OFX, Spengler D; Molecular 
Endocrinology, 2011 
Contributions to the publication: 
- involvement in revision process of the publication 
- preparation of plasmid standards for quantification of GR 1st transcripts  
- performing quantitative real-time PCRs 
- involvement in writing the publication.   
 
As described in the introduction, the promoter of the Nr3c1 gene is composed of multiple 
5’untranslated first exons, which give rise to various mRNA isoforms, but encode the same 
protein. While the structure of the rat and human GR 5’UTR were already established (Breslin 
et al. 2001; McCormick et al. 2000; Presul et al. 2007; Turner et al. 2005), the mouse GR 
promoter has been only partly characterised (F. Chen et al. 1999; Strähle et al. 1992). 
Therefore, in order to study epigenetic programming of the mouse GR, the structure of its 
5’end had to be determined. Our major finding (Bockmühl et al. 2011) is the characterisation 
of five novel first exons (1.3, 1.4, 1.9 and 1.12), in addition to five previously described ones 
(1.1,1.5, 1.6, 1.10 and 1.11) (F. Chen et al. 1999; Strähle et al. 1992). A schematic summary 
of mouse GR promoters is presented in Figure 6.  
 
3.1.1 Quantification and tissue distribution of GR first exons 
 We performed quantitative real-time PCR (qRT-PCR) in several central nervous system 
tissues (hippocampus, prefrontal cortex, hypothalamus), the pituitary, and various peripheral 
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tissues (liver, kidney, spleen, adrenals, and thymus), as well as in four clonal cell lines 
(corticotrope-derived AtT-20, hypothalamic N6, neuroblastoma N1E-115, and hippocampal 
progenitor HW3.5 cells). The absolute amounts for each exon were quantified based on a 
calibration curve, which was derived from amplification of set of standards of known 
concentration. Standards were obtained by serial dilutions of plasmid DNA, containing cloned 
partial target sequences. The forward primers were designed to be specific for each transcript, 
with the common reverse primer directed against exon 2. In addition, total GR was amplified 
using primers spanning coding exons 2 and 3. Expression of individual first exons was 
calculated as a percentage of total GR level in each tissue and cell line tested. Primer pairs 
used for expression analysis of mouse GR alternative first exons are listed in Table 1. 
As shown in Figure 8, the overall expression patterns seem to be rather similar in all tested 
neuronal tissues and cell lines (with the exception of the most distal promoter 1.1), whereas 
peripheral tissues show more variations. Exon 1.1 is highly expressed in the brain and 
pituitary, as well as in spleen and thymus (~10-88%). Exons 1.6 and 1.11 are the most 
abundantly expressed (~10-50%); while exon 1.10 appears to be expressed at a moderate level 
(~5%) in all tested tissues and cell lines. In general transcripts 1.3, 1.7 and 1.9 display the 
lowest expression levels (~1% or less). However, 1.9 is slightly higher expressed in N1E-115, 
N6, and AtT-10 cell lines, and 1.3 in the hypothalamus and the hypothalamic N6 cell line, in 
comparison to other tissues tested.  
Altogether, these results indicate that the expression of alternative GR first exons is not 
strictly tissue-specific. However, some alternative exons are preferentially expressed in 
certain tissues indicative of characteristic patterns of co-expressed transcript variants for each 
tissue and cell line tested, which contribute to total GR expression levels. 
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Figure 8: Expression and tissue distribution of GR first exon variants 
Percentage contribution of alternative first exons of total GR mRNA shown in neuronal tissues: hippocampus, 
prefrontal cortex (PFC), and hypothalamus; peripheral tissues: pituitary, liver, kidney, spleen, adrenals, thymus, 
and cell lines: HW3.5, N1E-115, N6, and AtT-20. Copy numbers of each individual exon were calculated 
according to calibration curves and shown relative to the total copy number of total GR mRNA. Copy numbers 
were means evaluated for each transcript from two independent qPCR runs using independent preparations of 
DNA standards. Experiments were conducted jointly with Yvonne Bockmühl, post-doc.	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3.1.2 Regulation of GR first exons expression 
Beside tissue- and cell- type specific expression patterns, the alternative GR transcripts are 
thought to be regulated by various environmental signals (Yudt and Cidlowski 2002). 
Therefore, we assessed the expression of GR first exons in response to various cellular 
signalling pathways. Specifically, we treated AtT-20 and N6 cell lines with basic fibroblast 
growth factor (bFGF) or K+-induced depolarization and subsequently analysed the expression 
of specific transcripts by quantitative RT-PCR.  
Among other growth factor, bFGF is produced in the anterior pituitary, where it stimulates 
corticotropic cell proliferation (van Wijk et al. 1995). Our results show that transcription of 
individual promoters is differently regulated by a 24 h treatment of pituitary AtT-20 cells with 
bFGF. We observed a strong induction of 1.5 exon and to a lesser extend of 1.3, 1.4c, 1.6, 1.7, 
and 1.11 (Figure 9a). This up-regulation of specific GR exon first transcripts contributed to 
the overall increase in total GR.  
It is well known, that neurons process and transmit their signals through cell membrane 
depolarization which can subsequently regulate the expression of certain genes (Flavell et al.  
2008). Here, K+ induced depolarization of hypothalamic N6 cells for 30 minutes induced the 
1.11 (major transcript in N6 cells) and 1.4 transcripts, as well as slightly enhanced levels of 
total GR. Moreover, we observed decreased expression of the 1.9 transcript, without 
influencing the levels of the 1.3, 1.5, 1.6, 1.7, 1.10, and 1.12a transcripts (Figure 9b). 
Prolonged (2h) depolarisation further decreased the 1.9 transcript and down-regulated the one 
of 1.6. The expression of exon 1.1 was strongly induced, but as a minor transcript in N6 cells 
it did not alter total GR. Other transcripts were unchanged. 
 
CHAPTER 3  RESULTS 	  
	  
	  
 
 
Figure 9: Regulation of GR first exon variants’ expression by cellular signalling 
A) Treatment of AtT-20 cell with the growth factor bFGF for 24h increases the expression of most of the 
identified transcripts, whereas others are not regulated. Expression of exon 1 transcripts was normalised to the 
internal standard Uros and Atp5j. Exon 1 transcripts of bFGF–treated cells are expressed as relative to 
expression of exon 1 transcripts in untreated cells. B) K+-induced depolarization of N6 cells for 30 min and 2 h 
differentially regulates exon 1 transcripts. Expression of exon 1 transcripts was normalised to internal standard 
G6pdx. Exon 1 transcripts of depolarized cells are expressed as a function of expression of exon 1 transcripts in 
untreated cells. Data represent two independent experiments performed in triplicate (a) 2 or duplicate (b). Error 
bars are SEM (a) *P< 0.04; **P< 0,003. (b) *P< 0.025; § P<0.001, assessed  by t-test. Experiments were done 
jointly with Yvonne Bockmühl, post-doc. 
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Moreover, it is important to note that, in addition to regulation of multiple GR first exons by 
cellular signalling (Figure 9), formation of alternative transcripts results in differential control 
of mRNA stability and translation efficiency as shown by (Bockmühl et al. 2011). This might 
add another layer for tight control of GR expression in a tissue- and cell- type specific 
manner.  
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3.2 Epigenetic programming of the GR by ELS 
 
Work done as part of a publication:  
“Epigenetic underpinnings of adverse experience-dependent resilience” Bockmühl Y, Patchev 
A, Madejska A, Hoffmann A, Sousa J, Sousa N, Holsboer F, Almeida OFX, Spengler D; 
Epigenetics, April 2015  
Contributions to the publication: 
- involvement in planning and performance of the experiments, including expression, 
methylation and chromatinimmunoprecypitation experiments 
- micropunching of frozen brain tissue  for methylation, expression and 
chromatinimmunoprecipitation experiments 
- preparation of frozen brain tissue for IHC and ISH experiments 
- involvement in writing the publication.   
 
3.2.1 Conserved methylation pattern of ELS-responsive YY1 binding site 
To exclude that our methylation results are strain specific and to show that changes in the 
degree of methylation of the ELS-responsive YY1 binding site can also potentially occur in 
another mouse strain than C57BL/6N inbred mice, we assessed the methylation pattern in 
CD1 outbred mice. Analyses were performed in 10 weeks old male mice without a history of 
ELS. Several brain areas (hippocampus, PFC, and hypothalamus) and peripheral blood 
mononuclear cells were compared to show that CpG island shore methylation is conserved in 
different tissues. Specifically, we analysed the methylation status of the region comprising 
CpG1-9. Hereby, CpG3 corresponds to the distal YY1 binding site (Figure 10).  
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Figure 10: Sequence of mouse GR promoter fragment used for methylation analysis 
The sequence at the CGI shore region of the mouse GR promoter, covering CpG1-9 (yellow), is shown. CpG3 
corresponds to a putative YY1 transcription factor binding site (turquoise). Grey boxes represent sequences 
corresponding to bisulfite specific primers. Red lines correspond to CGIs. 
 
 
Single clone bisulfite sequencing revealed similar methylation patterns of the CpG island 
shore region at the GR promoter between both mouse strains (Figure 11). In neuronal tissues 
of CD1 outbred mice we observed slightly higher DNA methylation at CpG3 (~25%) in 
comparison to C57BL/6N inbred mice (~10%). The methylation level in peripheral blood was 
comparable (20-25%) between both strains. These results confirmed that CpG methylation at 
the mouse YY1 binding site within the GR promoter is shared between inbred and outbred 
strains.  
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Figure 11: DNA methylation at the CGI shore region of the mouse GR promoter 
CpG methylation was analysed by bisulfite sequencing and single clone reading using tissue from the PVN, 
hippocampus, and peripheral blood cells of 10 weeks old C57BL/6N inbred mice (n=5) A) and, hypothalamus, 
hippocampus, and peripheral blood cells of 10 weeks old CD1 outbred mice (n=5) B). 20-24 clones were 
sequenced per animal. The work was done jointly with Yvonne Bockmühl, post-doc. 
 
 
Given the fact, that the structure of the human and mouse GR promoters is highly conserved, 
including the distal YY1 binding site [Figure 6, (Bockmühl et al. 2011; Breslin et al. 1998)], 
we asked next whether CpG methylation at these sites can be found also at the human GR 
promoter. Such findings could open the possibility of epigenetic programming of human GR 
CHAPTER 3  RESULTS 	  
	  
	  
via mechanism related to YY1 binding. To address this topic, we initially performed 
sequencing analysis using bisulfite converted DNA isolated from various human 
neuroblastoma cell lines. In addition, we used peripheral blood mononuclear and buccal swap 
cells as well as post mortem brain samples (inferior cortex, hippocampus, and hypothalamus) 
obtained from male individuals without detectable brain pathology at the time of death. 
We analysed the region of the human GR promoter sequence covering CpG1-11; human 
CpG7 is part of the putative distal YY1 binding site, identified previously (Breslin et al. 
1998) and corresponds to mouse CpG3 (Figure12). 
 
 
Figure 12: Sequence of the human GR promoter fragment used for methylation analysis 
The sequence of the CGI shore region of the human GR promoter, covering analysed CpG1-11 (yellow). CpG7 
corresponds to a putative distal YY1 transcription factor binding site (turquoise). Grey boxes represent 
sequences corresponding to bisulfite specific primers 
 
Our studies revealed moderate methylation (5-10%) at CpG7 among all tested human cell 
lines as well as neuronal and peripheral tissues (Figure 13). Together with the mouse data, 
these results suggest cross-species conservation of the CGI shore region methylation pattern 
and a possible regulation by YY1 in a methylation-dependent manner. In view of these 
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findings, our post mortem studies open up the possibility for comparisons between the 
methylation patterns from control subjects and patients suffering from psychiatric disorders. 
Such findings could further strengthen the importance of YY1 binding for GR expression. 
However, due to limited access to post mortem brain tissues from control subjects and 
patients, we were unable to answer this question. 
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Figure 13:  DNA methylation at the CGI shore region of the human GR promoter  
CpG methylation was analysed by bisulfite sequencing and single clone reading in the human neuroblastoma cell 
lines (SKNMC, Be2M17, and SHSY5Y) and A) post mortem brain samples (hypothalamus n=4, hippocampus 
n=6, and cortex n=10) obtained from control subjects and, B)  buccal swap and peripheral blood cells from 
healthy donors n=11 C). 20-24 clones were sequenced per sample. 
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3.2.2 Up-regulation of multiple GR first exons in ELS mice 
As shown previously, the GR is composed of multiple 5’-untranslated first exons, which give 
rise to the same protein (Bockmühl et al. 2011; Breslin et al. 2001; Turner et al. 2005). 
Moreover, some of the identified GR first exons might be differentially regulated by various 
stimuli, including growth factor- and depolarization-dependent signalling (Figure 9). In order 
to investigate if specific GR transcripts are regulated by ELS, leading to changes of total GR 
mRNA, quantitative RT-PCR was performed with RNA isolated from PVNs of 10 days and 3 
month old control and ELS mice. This experiment revealed strong up-regulation of 1.4c and 
1.7 transcripts in 10 days old mice with a history of maternal separation (Figure 14a). 
However, as less prevalent transcripts, they contribute weakly to total GR, the expression of 
which is not changed in these mice (Bockmühl et al. submitted). On the other hand, in 3 
month old ELS mice we observed an up-regulation of multiple GR transcripts; including 
major 1.6 and 1.11, which contribute strongly to increased total GR mRNA expression. Strong 
induction of minor transcripts 1.9 and 1.12 had probably less effect on the final result. 
Noticeably, 1.7 exon was not altered (Figure 14b). 
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Figure 14: Regulation of GR first exons in PVN by ELS 
GR exon 1 transcripts were quantified by quantitative RT-PCR in 10 days A) and 3 month B) old ELS and Ctrl 
mice (n = 7-9 per group). Data are shown relative to the expression levels in the control group and normalized 
with Atpj5 as internal reference and relative to the expression of the Ctrl group (n = 7-9). Error bars are SEM 
*p< 0.05; **p< 0.01; ***p< 0.001, assessed  by t-test. These experiments were done jointly with Yvonne 
Bockmühl, post-doc. 
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3.2.3 GR protein levels in the PVN 
GR protein expression in the PVN was assessed by immunohistochemistry (IHC). Triple 
staining of GR, Crh and Avp was performed on PVN sections obtained from mice with a 
history of MS or controls. Our findings of higher GR protein levels in ELS mice (Figure 15) 
argue against an impaired negative feedback. IHC revealed unaltered Crh expression in ELS 
mice and Avp up-regulation, as shown previously (Murgatroyd et al. 2009). Interestingly, as 
evidenced in Figure 15b, GR expression is restricted to Crh positive neurons and was absent 
in Avp positive neurons indication that GR up-regulation in response to ELS occurred in a 
cell-type specific manner. 
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Figure 15: Representative images of immunohistochemical triple-staining to detect GR, Crh and Avp  
ELS led to increased immunostaining of GR and Avp, having no influence on Crh A). Colocalization of GR/Crh 
(right panel) and lack of colocalization GR/Avp (left panel) on PVN sections from control Ctrl and ELS mice B). 
Scale bar = 50 µm. Primary and secondary antibodies used for triple-staining of GR, Avp and Crh are listed in 
Table 5. Work done jointly with Yvonne Bockmühl, post-doc. 
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3.2.4 GR signalling in ELS mice 
Given the fact that GR serves as a main regulator of the HPA axis, its proper expression and 
function is necessary for sufficient negative feedback regulation, what is especially important 
in the context of different pathologies (de Kloet et al. 2005).  In this respect, impaired GR 
signalling has been postulated as a key mechanism involved in the hyperactivity of the HPA 
axis (Anacker et al. 2011; Holsboer 2000). Previous work in our laboratory revealed that 
maternal separation, used to induce ELS in mice, leads to sustained hyperactivity of the HPA 
axis. For that reason, we asked whether elevated GR protein levels in ELS mice resulted in 
enhanced transcriptional activity. To address this question, we investigated the expression 
profiles of classical target genes. Several candidates were selected that were shown earlier to 
be inducible in rodent hypothalamus by corticosterone or stress, such as genes coding for: 
FK506 binding protein 5 (Fkbp5) (Hubler et al. 2004); serum-and glucocorticoid-induced 
protein kinase (Sgk1) (Sarabdjitsingh et al. 2010); Glucocorticoid-induced leucine zipper 
(Gilz) (Sarabdjitsingh et al. 2010); down-regulated in renal cell carcinoma 1 (Drr1) (Schmidt 
et al. 2011); pyruvate dehydrogenase kinase 4 (Pdk4) (Ding et al. 2010); and dual specificity 
phosphatase 1 (Dusp1) (Tchen et al. 2010). We performed qRT-PCR using primers listed in 
Table 1. Analysis was performed in PVNs of 10 weeks old male mice (control / ELS) that 
have received a single acute intraperitoneal (ip) injection of corticosterone (0.1; 1.0 and 10.0 
mg/kg). Animals were sacrificed 3 hours after injection. Tissue from the dentate gyrus, where 
GR mRNA levels did not differ between control and ELS mice, was used as a negative control 
In concordance with previously published data (Scharf et al. 2011), corticosterone treatment 
resulted in a dose-dependent increased expression of all tested GR target genes in PVN 
(Figure 1b). As we did not observe differential expression of these genes after intraperitoneal 
saline injection, the data from corticosterone application were referred to those from saline 
application which were set to one. The data were analysed by two- way ANOVA and show 
CHAPTER 3  RESULTS 	  
	  
	  
that maternal separation (stress) enhanced GR protein levels in the PVN and significantly 
increased the expression of the Fkbp5, Sgk1 and Dusp1 genes (p<0.001, p< 0.1, p<0.1), 
respectively (Table 6). These findings can be explained by the fact that Fkbp5, Sgk1 and 
Dusp1encode a maximum of two GREs (Arteaga et al. 2008; Hubler et al. 2004; Tchen et al. 
2010). Therfore, their inducibility may be facilitated when GR expression is increased. On the 
other hand, Gilz, Drr1, and Pdk4 do not show an effect of stress. Nevertheless, they all show 
an significant effect of CORT injection (p<0.0001, p<	   0.0001, p< 0.000001 respectively) 
similar to Fkbp5, Sgk1 and Dusp1 (p<0.0001, p<	  0.001, p<0.0001). This shows that all of 
these genes are responsive to CORT, but only some are directly regulated (their expression is 
influenced by ELS-induced GR up-regulation). There is no interaction effect of stress x 
CORT observed for all tested genes. Altogether, our expression data suggest that the level of 
activated GR is important in the regulation of certain target genes while others behaving 
largely indistinguishably between ELS and control mice might be regulated by additional 
mechanisms unrelated to GR.  
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Figure 16: Expression of GR target genes in the hypothalamic PVN  
Intraperitoneally injected corticosterone (Cort; 0.1, 1.0, 10.0 mg/kg) induced GR-responsive genes in the PVN of 
10-weeks old Ctrl and ELS mice, as measured by qPCR. Increased GR expression in ELS mice translates to 
higher GR transactivation, as shown by higher expression of some GR target genes, containing in their sequence 
appropriate GREs. Expression data are normalized to Atpj5; fold-induction is shown; Error bars are SEM.; n = 4-
8 animal per group. Data were analysed by two -way ANOVA (Stress, CORT) with Stress (ELS,Ctrl) and CORT 
(0.1, 1.0, 10 mg/kg), followed by Newman-Keuls post-hoc test, if appropriate (statistical analysis are shown in 
Table 6); * p< 0.05, ** p< 0.01 
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Protein Stress CORT Stress x CORT 
Fkbp5 
 
F(1,30) = 19.85, p< 0.001 F(2,30) = 63.65, p< 0.0001 F(2,30) = 1.644, p= 0.210 
Sgk1 
 
F(1,31) = 4.27, p< 0.1 F(2,31) = 6.97, p< 0.001 
 
F(2,31) = 1.30, p= 0.28 
Drr1 
 
F(1,29) = 0.29, p= 0.59 F(2,29) = 38.52, p< 0.0001 
 
F(2,29) = 0.27, p= 0.76 
Gilz 
 
F(1,31) = 0.04, p= 0.83 F(2,31) = 21.20, p< 0.0001 
 
F(2,31) = 0.75, p= 0.47 
Dusp1 
 
F(1,27) = 6.01, p< 0.1 F(2,27) =11.05, p< 0.01 F(2,27) = 3.12, p= 0.06 
Pdk4 F(1,31) = 0.00055, p= 0.98 F(2,31) = 28.42, p< 0.000001 
 
F(2,31) = 1.05, p= 0.36 
 
Table 6: Statistical analysis of Fig. 16 
 
In the next step we analysed the expression of the same set of GR target genes in the dentate 
gyrus (DG). As shown in our previous work, the DG is a tissue for which we did not observe 
differential expression of GR in response to maternal separation (Bockmühl et al. submitted). 
We analysed the expression of Fkbp5, Sgk1 (in the PVN their expression is induced stronger 
in ELS mice following CORT injection) and Drr1 (in the PVN no differences between naïve 
and ELS mice following CORT injection). The data were analysed by two- way ANOVA and, 
in the case of Fkbp5 and Sgk1, we did not observe any effect of stress. Fkbp5 shows a 
significant effect of CORT injection (p<0.0001 (Table 7)). Similar to previously reported 
results (Scharf et al. 2011), we observed that in tissues with low basal expression of Fkbp5 
(e.g.; PVN) induction of its expression is much stronger than in tissues with high basal 
expression (e.g.; hippocampus) (Figure 16 and 17). Moreover, in hippocampal DG single 
corticosterone injection did not affect Sgk1 mRNA expression, what is in concordance with 
another earlier study (van Gemert et al. 2006). On the other hand, Drr1 gene shows a stress 
effect (p< 0.001 (Table 7)), suggesting additional layers of gene regulation, independent of 
GR signaling. There is no interaction effect of stress x CORT for all tested genes. 
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Figure 17: Expression of GR target genes in the hippocampal DG 
Intraperitoneally injected corticosterone (Cort; 0.1, 1.0, 10.0 mg/kg) induced slightly Fkbp5, and did not change 
Sgk1 and Drr1 expression in the DG of Ctrl and ELS mice, as measured by qPCR. In contrast to the PVN, Fkbp5 
and Sgk1 expression did not differ between Ctrl and ELS mice; increased Drr1expression in ELS mice was 
observed with higher Cort doses. Expression data are normalized to Atpj5; fold-induction is shown; Error bars 
are SEM; n = 4-8 animal per group. Data were analysed by two -way ANOVA (Stress, CORT) with Stress 
(ELS,Ctrl) and CORT (0.1, 1.0, 10 mg/kg), followed by Newman-Keuls post-hoc test, if appropriate (analysis 
shown in Table 7); * p< 0.05, ** p< 0.01 
	  
Protein Stress CORT Stress x CORT 
Fkbp5 F(1,34) = 1.08, p=0.30 F(2,34) = 13.77, p< 0.0001 
 
F(2,34) = 0.32, p< 0.72 
Sgk1 F(1,34) = 2.17, p=0.14 F(2,34) = 0.34, p= 0.7 
 
F(2,34) = 1.230, p= 0.3 
Drr1 F(1,34) = 19.25, p< 0.001 F(2,34) = 1.13, p= 0.33 
 
F(2,34) = 0.19, p= 0.82 
 
Table 7: Statistical analysis of Fig. 17 
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3.2.5 Expression analysis of genes down-regulated by GR in PVN 
In addition, we assessed the expression of crucial components of the HPA axis known to be 
repressed by GR, i.e.; Avp and Crh. A two- way ANOVA analysis revealed neither significant 
effects of stress nor CORT injection. There is also no significant stress x CORT interaction 
observed. In opposite to our expectations, we were unable to detect their down-regulation 
with increasing doses corticosterone by qRT-PCR (Figure 18). Similarly, in situ hybridisation 
carried out on PVN sections obtained from mice injected with 1.0 mg/kg CORT, using a 
radioactively labelled probe against Avp and Crh did not show decreased mRNA expression 
(data not shown). It is important to mention, that our IHC results (Figure 15b) revealed no co-
localization between GR and Avp.   
 
Figure 18: Expression of genes down-regulated by GR 
Intraperitoneally injected corticosterone (Cort; 0.1, 1.0, 10.0 mg/kg) did not regulate significantly Avp and Crh 
expression in the PVN, as measured by qPCR. Expression data are normalized to Atpj5; fold-induction is shown; 
Error bars are SEM; n = 4-8 animal per group. Data were analysed by two- way ANOVA (Stress, CORT) with 
Stress (ELS,Ctrl) and CORT (0.1, 1.0, 10 mg/kg). Analysis shown in Table 8 
 
 
 
Protein Stress CORT Stress x CORT 
Avp F(1,31) = 1.09, p= 0.30 F(2,31) = 3.19, p=0.54 
 
F(2,31) = 0.77, p= 0.47 
Crh F(1,31) = 2.79, p= 0.1 F(2,31) = 1.16, p= 0.32 
 
F(2,31) = 2.42, p= 0.1 
 
Table 8: Statistical analysis of Fig. 18 
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3.2.6 GR occupancy at exemplary GREs in the PVN 
Following activation by GCs, glucocorticoid receptors translocate to the nucleus and exert 
their effects by binding to specific glucocorticoid response elements (GREs) located within 
regulatory regions of GR target genes (van der Laan et al. 2008). Since our expression 
analysis (Figure 16a) have shown differential regulation of three GR target genes (Fkbp5, 
Sgk1, and Dusp1), we performed an in vivo chromatin immunoprecipitation (ChIP) assay 
using PVNs of 10 weeks old male mice (control/ELS) injected intraperitoneally with one dose 
of corticosterone (1.0 mg/kg) or saline. Animals were sacrificed 90 minutes after injection. 
The recovered DNA containing target gene sequences for GR from the PVNs was clearly 
enriched after immunoprecipitation with the anti-GR antibody, as compared to the negative 
control without antibody (data not shown). The data presented here (Figure 19) were analysed 
by two- way ANOVA (Table 9) and support the hypothesis that, in comparison to controls, 
elevated GR levels in ELS mice lead to higher occupancy at the intronic DNA-binding site of 
Fkbp5 and one of the two sites of Dusp1 (GRR-29). Therefore, this set of data proves the 
functionality and increased signalling of up-regulated glucocorticoid receptors in ELS mice in 
the PVN. In case of Sgk1 we did not detect any significant differences in GR occupancy at the 
GRE located distally from the TSS between animals with a history of maternal separation and 
controls.  
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Figure 19: GR occupancy at GREs of exemplary target genes in the PVN 
Increased GR expression in ELS mice translates to higher GR occupancy at regulatory regions of exemplary target genes, as 
shown by in vivo ChIP. Recovered DNA was analysed by qPCR and normalized to non-precipitated input chromatin. For 
this, 3 PVNs from 10-week old mice were pooled for 5 ChIP analysis (n = 15 per group). Error bars are SEM. *P< 0.05.  
Data were analysed by two- way ANOVA (Stress, CORT) with Stress (ELS,Ctrl) and CORT (1.0 mg/kg), followed by 
Newman-Keuls post-hoc test, if appropriate (analysis shown in Table 9) *** p< 0.001, ** p< 0.01, * p< 0.05 
	  
Protein Stress CORT Stress x CORT 
Fkbp5 F(1,14) = 6.58, p< 0.1 F(2,14) = 17.49, p< 0.001 
 
F(2,14) = 0.26, p= 0.61 
Sgk1 F(1,14) = 0.34, p= 0.56 F(2,14) = 25.30, p< 0.001 
 
F(2,14) = 1.66, p= 0.21 
Dusp1 F(1,14) = 4.28, p< 0.1 F(2,14) = 14.54, p< 0.001 
 
F(2,14) = 1.17, p= 0.35 
 
Table 9: Statistical analysis of Fig. 19 
	  
.   
3.2.7 GR occupancy at exemplary GREs in Dentate Gyrus 
To strengthen our hypothesis of important ELS-dependent differences in GR expression in the 
PVN, we investigated the GR occupancy at GREs in the dentate gyrus as well. As expected, 
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no significant differences in GR binding to GREs of exemplary target genes were reported 
(Figure 20).  
 
 
Figure 20: GR occupancy at GREs of exemplary target genes in the DG 
ELS did not increase GR occupancy at regulatory regions of exemplary target genes, as shown by in vivo ChIP. Recovered 
DNA was analysed by qPCR and normalized to non-precipitated input chromatin. For this, DG from three 10-week old mice 
were pooled for 5 ChIP experiments (n = 15 per group). Error bars are SEM. Data were analysed by two- way ANOVA 
(Stress, CORT) with Stress (ELS,Ctrl) and CORT (1.0 mg/kg), 
	  
Protein Stress CORT Stress x CORT 
Fkbp5 F(1,16) = 1.90, p= 0.18 F(2,16) = 0.32, p= 0.58 
 
F(2,16) = 0.048, p= 0.82 
Sgk1 F(1,16) = 1.07, p= 0.82 F(2,16) = 1.03, p= 0.46 
 
F(2,16) = 0.28, p= 0.57 
 
Table 10: Statistical analysis of Fig. 20 
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In the present work we focused on epigenetic programming of GR by early-life stress. For that 
purpose, in the first part of the study, it was necessary to establish the structure of the mouse 
GR promoter, as well as tissue distribution of GR alternative first exons and their regulation 
by various signaling pathways. We found that, although most of alternative first exons are 
widely expressed in different brain and peripheral tissues and in clonal cell lines, their 
transcription can be differently regulated by growth factor- and depolarization-induced 
signaling.  
As already stated in introduction, GR gene expression is highly dependent on multiple 
untranslated first exons, which give rise to alternate RNA isoforms, but encode the same 
protein. While the composition of the rat and human GR promoters was known (Breslin et al. 
2001; Turner et al. 2005; Presul et al. 2007; McCormick et al. 2000), knowledge of the mouse 
homolog was missing. Therefore, we carried out a detailed analysis and identified four new 
transcripts in addition to five previously described untranslated first exons (Strähle et al. 
1992). These findings have been recently published (Bockmühl et al. 2011).  
Moreover, the tissue-specific distribution of different first exons has been examined 
previously in a wide range of human and rat tissue (Alt et al. 2010; McCormick et al. 2000; 
Turner et al. 2005) and to a lesser extent in mouse (Strähle et al. 1992). For that reason 
absolute quantification and tissue distribution of GR first exons were analysed. Interestingly, 
we did not detect clear tissue-specific expression patterns of mouse GR alternative first exons 
(Figure 8). However, as shown for human (Turner et al. 2005; Alt et al. 2010), mouse GR 
transcripts display a conserved expression pattern across all neuronal tissues tested, whereas 
more variations were reported throughout peripheral tissues. We observed also some between-
species discrepancies. Whereas, human 1B and 1C (Alt et al. 2010; Breslin et al. 2001; Turner 
et al. 2005), and their rat homologs 1.6 and 1.10 (McCormick et al. 2000) are reported to be 
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the most abundantly expressed, we showed 1.6 and 1.11 (but not 1.10) to be the major 
transcripts among all tested mouse tissues. Moreover, the most distal human 1A (Presul et al. 
2007), rat 1.1 (McCormick et al. 2000) and mouse 1.1 (previously known as 1A) (Strähle et 
al. 1992) were reported to be specific for hemapoetic cell lines and thymocytes. In the present 
study, we detected 1.1 to be abundantly expressed also in brain (hippocampus, PFC, and 
hypothalamus), pituitary, thymus, adrenals, and spleen, and to lesser extend in kidney and 
liver. Importantly, as most of the researches investigate currently the expression of rat 1.7 
transcript (Weaver et al. 2004) and its human homolog 1F (McGowan et al. 2009), we show 
that mouse 1.7 is a minor transcript in all tested tissues and represents ~1 % of total GR 
mRNA. Similar levels of 1F expression (~1% of total GR mRNA) in human were detected by 
Alt et al. (2010). These results are in contrast to those of McGowan et al. (2009) who reported 
this transcript to contribute by 40-60% to the total amount of GR.  
Given the presence of multiple GR promoters and their diverse expression patterns in various 
tissues, it has been hypothesized that these transcripts might be differentially regulated by 
various environmental stimulus (Ayoubi et al. 1996). Thus, we assessed regulation of multiple 
GR promoters in response to cellular signals, including growth factors and potassium-induced 
depolarization (Figure 9). In this study we found expression of most of first exons to be 
affected in all tested conditions. Especially, treatment of AtT-20 corticotropic cells with bFGF 
resulted in strong induction of exon 1.5 transcript and, to a lesser extent, 1.3, 1.4c, 1.6, and 
1.7. On the other hand, 30 minutes of N6 cells depolarization led to increased expression of 
exon 1.4c and 1.11, and decreased levels of exon 1.9. Moreover, our further studies described 
in Bockmühl et al. (2011), show that alternative GR transcripts differently influence mRNA 
stability and translation efficiency. All these findings together reflect a transcriptional and 
posttranscriptional mechanisms that serve as a tight and tissue- specific control of GR 
expression upon varying physiological demands.  
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The second part of the thesis provides the evidence for ELS- induced DNA methylation 
changes at CpG3 within GR promoter and up-regulated expression of GR in hypothalamic 
Crh- releasing neurons (Figure 15). We further demonstrate that observed enhanced GR 
expression translates into higher GR protein transcriptional activity. The latter is shown by 
increased occupancy of GR at regulatory regions of GR target genes (Figure 19) and their 
induced expression levels (Figure 16).  
Given the fact that almost all identified mouse GR first exons lie within an upstream CpG 
islands, it was hypothesized that DNA methylation at the GR promoter might be responsible 
(at least in part) for regulation of GR expression (Bockmühl et al. submitted). Extensive 
methylation analysis of the whole mouse GR promoter, covering 3.4 kb of the untranslated 
exonic region, revealed only sparse methylation (Bockmühl et al. submitted). These 
observations are consistent with the concept of methylation-free promoters associated with 
CGIs (Deaton et al. 2011). In contrast, upstream of exon 1.3 at the CGI shore, moderate levels 
of DNA methylation were detected. Bisulfite sequencing revealed hypermethylation of a 
specific CpG residue (CpG3) in adult mice with a history of ELS. Computational analysis 
predicted the differentially methylated CpG to be part of a putative binding site for the 
multifunctional transcription factor Yin Yang 1 (YY1) (Bockmühl et. al. submitted). This site 
is homologues to a previously identified distal YY1 binding site (dYY1) within the human 
GR (Breslin et al. 1998).   
It is important to note, that one study (Weaver et al. 2004) reported relatively high level of 
methylation at the investigated 1.7 rat GR promoter region (~15-100%). Their findings were 
so far only partly reproduced by other researches. For example, MS applied at PND2-PND14 
in Sprague Dawley rats has been shown to increase plasma corticosterone release and 
behavioral abnormalities. However, the authors detected unaltered methylation at the GR 1.7 
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promoter (Daniels et al. 2009). In recent post mortem studies, despite decreased level of 1F 
transcript in the hippocampus of MDD patients, the authors did not find differential 
methylation of the GR 1F promoter, probably due to the overall low methylation level. 
Importantly, total GR mRNA expression was unchanged (Alt et al. 2010). In addition 
extensive methylation analysis of the mouse GR promoter performed in our laboratory 
revealed almost no methylation at 1.7 (Bockmühl et al. submitted). These discrepancies 
between studies may result from strain-specific differences (Long-Evans vs Sprague Dawley), 
species-specificity (human versus rat versus mouse) and different type of stressors 
experienced (MS versus low or high maternal care).  
Therefore, to prove that our previously reported methylation results are not strain specific 
(i.e.; confined to C57BL/6N mice), we analysed the methylation status at the YY1 binding 
site within the CGI shore region of the GR promoter in the hypothalamus, hippocampus and 
blood of CD1 mouse and compared to C57BL/6N. Indeed, the data provide evidence 
indicating a conserved methylation pattern at the region of interest. Additionally, we observed 
a similar methylation pattern among all tissues tested (Figure 11), suggesting a conserved 
methylation at the YY1 binding site across tissues.  
Given the high homology between the mouse and human GR promoter, we aimed to study 
whether methylation at the distal YY1 binding site occurs in human as well. In fact, we found 
methylation in various human neuroblastoma cell lines, cells from buccal swabs, and blood 
drowns as well as in post mortem brain samples. These findings indicate a potential regulation 
of the human GR by YY1 and might serve as a start point for the comparison of methylation 
patterns in tissues from control subjects and patients with stress-related brain disorders. 
However, due to the limited access to human brain tissues, we were unable to follow-up this 
question. 
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However, several studies have reported that alterations in epigenetic marks of genes 
previously implicated in development of brain disorders might be detectable across peripheral 
tissues and can distinguish patients from controls (Dempster et al. 2011; Heyn et al. 2012; 
Masliah et al. 2013). These results suggest that peripheral blood cells might serve as a 
clinically valuable surrogate for brain tissue, given the easy access to this source in patients. 
Importantly, as shown in Figure 11 and 13, we identified concordant methylation patterns at 
the GR promoter between brain and blood, both in human and mouse. Consequently, it would 
be of interest to investigate the methylation pattern at the GR promoter in the blood of ELS 
mice. In case of peripheral methylation changes in mice, the same region of the human GR 
promoter could be assessed in the blood cells of depressed patients with a history of childhood 
adversity. Changes in GR promoter methylation in peripheral blood cells might resemble 
changes occurring in the brain and can serve as a potential easy accessible and non-invasive 
molecular biomarker of altered GR functioning in relation to specific psychiatric diseases 
following a previous stress history. 
As already mentioned, corticosteroids which are on one side essential for brain function, can 
also lead to development of pathological states within brain structure and function (de Kloet 
et al. 2005). This effect highly depends on the timing and duration of the exposure, and 
previous history of stress (Lupien et al. 2009). One of the most vulnerable time points in life 
is the early postnatal period, characterized by a high plasticity of the developing brain, and its 
sensitivity for programming and mal-programming by endogenous and exogenous factors 
(Herman et al. 2013;  de Kloet et al. 2005). Therefore, adverse life events experienced during 
this period are thought to induce long-lasting changes in the endocrine and behavioral 
phenotype (Andersen et al. 2003). In rodents, disruption of the pup-mother relationship is one 
of the most potent early-life stressors and can lead to the development of a vulnerable 
phenotype with an increased reactivity to stress in adulthood (de Kloet et al. 2005; Lupien et 
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al. 2009). In fact, as shown previously in our laboratory, mice with a history of MS display in 
adulthood depression-like symptoms such as an enduring dysregulation of the HPA axis, 
including increased basal secretion of GCs, hyperreactivity to an acute stress applied later in 
life, and an impaired response to the dexamethasone suppression test (Murgatroyd et al. 
2009), indicating an impaired GC-mediated negative feedback. The latter is suggested to 
occur due to a reduced function or expression of GR within tissues involved in HPA-axis 
regulation (Zunszain et al. 2011; Carvalho et al. 2008). This is possibly caused by an altered 
function of the glucocorticoid receptor (Anacker et al. 2011), which is supported by the 
results of the dexamethasone suppression test (DST), showing inappropriate inhibition of 
cortisol secretion in depressed patients (Holsboer et al. 2000). Indeed, previous work in our 
lab revealed decreased responsiveness to dex application in ELS mice, as compared to 
controls, suggesting reduced negative feedback efficiency (Murgatroyd et al. 2009). 
Surprisingly, the same mice do not show a down-regulation of GR mRNA expression at any 
level involved in the regulation of the HPA axis. Our present study revealed actually an up-
regulation of GR, the effect restricted to in the hypothalamic PVN (Bockmühl et al. 
submitted). This finding is distinct to current knowledge regarding GR expression in the brain 
of individuals with a history of early life adversity. For example, decreased hippocampal GR 
expression was reported in suicide victims who experienced childhood abuse in comparison to 
controls and suicide victims without a history of ELS (Labonte et al. 2012; McGowan et al. 
2009). Moreover, adult rat offspring receiving low maternal care show decreased 
hippocampal GR expression and reduced glucocorticoid feedback sensitivity in comparison to 
offspring of high-caring mothers (Liu et al. 1997). These discrepancies between studies could 
be related to species-specificity between human, rat and mouse, or types of experienced 
stressor (maternal separation, quality of maternal care and childhood abuse),	  however further 
studies would be necessary to clarify this matter,  
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Numerous studies in human and rodents indicate that hyperactivity of the hypothalamus–
pituitary–adrenal axis and consequently increased levels of glucocorticoid hormones occur 
due to impaired GR-mediated negative feedback. Given our previous results about regulation 
of GR first exons by various signaling pathways (Figure 9), it was examined whether 
expression of specific transcripts is modulated by ELS. We observed up-regulation of 
multiple transcripts in the hypothalamic PVNs of 3 month old mice with a history of maternal 
separation (Figure 14). This finding is consistent with our previous observation of increased 
total GR mRNA (Bockmühl et al. submitted) and protein levels (Figure 15a). Up-regulation of 
the major transcripts 1.6 and 1.11 contributed in particular to an increase in total GR mRNA. 
It is important to note that exon 1.7, previously reported by Weaver et al. (2004) to be 
responsive to the quality of maternal care was not altered. Together, these results indicate that 
in mice multiple GR promoter transcript respond to environmental signals induced by 
postnatal stress exposure when compared to rat. 
Given the fact that alternative GR first exons differ in their RNA stability and translation 
efficiency (Bockmühl et al. 2011), it raised the question of whether enhanced GR mRNA 
levels translate into higher GR protein levels. Indeed, our IHC results indicate elevated GR 
protein levels exclusively in PVN of ELS mice (Figure 15).  
In order to assess the biological relevance of increased total GR mRNA and GR protein 
expression in the PVN of MS mice, transcriptional activity of GR was tested. Indeed, 
quantitative RT-PCR analysis demonstrated stronger induction of some GR downstream 
target genes in ELS vs. control mice, following intraperitoneal corticosterone injection. Genes 
containing in their sequence up to two glucocorticoid response elements (GREs), i.e. Fkbp5, 
Sgk1, and Dusp1 (Arteaga et al. 2008; Hubler et al. 2004; Tchen et al. 2010), showed a 
differential regulation in ELS mice, suggesting that their inducibility may be facilitated when 
GR expression is increased. Importantly, we did not observe enhanced GR-dependent 
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expression of Fkbp5 and Sgk1 in those tissues where GR expression was unaltered, i.e.; the 
hippocampal DG (Figure 17). Moreover, we could support improved GR signaling in the 
PVN by higher GR occupancy at the intronic GRE site of Fkbp5 and at one of the two sites of 
Dusp1 (GRR-29), as demonstrated by in vivo ChIP experiments on chromatin isolated from 
the PVN of corticosterone-treated ELS mice (Figure 19). In the case of Sgk1, we did not 
detect any significant differences in GR occupancy at the GRE located distally from the TSS 
between ELS mice and controls. This might be explained by the fact that Sgk1 belongs to the 
group of immediate early genes and its transcription occurs rapidly (> 20 minutes) in response 
to various cellular signals (Lang et al. 2010). Hence, GR might be partly released from the 
Sgk1 GRE, while differences on mRNA level are still present. In the DG GR occupancy at the 
Fkbp5 and Sgk1 genes was unchanged (Figure 20).  
Importantly, in the present work we detected GR expression to be confined only to Crh-
producing neurons, which are important regulators of the HPA axis (Figure 15b and (de Souza 
et al. 2010). Moreover, the direct action of GR on Crh is supported by the in vivo ChIP data, 
showing upon intraperitonal corticosterone application GR binding to the negative GRE 
(nGRE) localized at the Crh promoter (Bockmühl et al. submitted). On the other hand, Avp 
and GR do not co-localize in the PVN arguing against a cell-autonomous mechanism (Figure 
15b). Lack of co-localisation between GR and Avp might explain the inability of 
glucocorticoids to suppress Avp expression in ELS mice [Figures 15b and 18, and (Liposits et 
al. 1987)]. Conversely, this lack of GR expression in Avp positive neurons might make Avp a 
particular suitable target for ELS dependent epigenetic programming.   
One of the possible explanations for the physiological function of up-regulated GR in ELS 
mice might be a compensatory response to increased Avp mRNA in the PVN. This view is 
supported by the delayed increases of hypothalamic GR levels in mice with a history of 
maternal separation. Changes in GR expression become evident in early adulthood (6 weeks 
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of life) (Bockmühl et al. submitted), whereas changes in Avp mRNA expression, as shown by 
Murgatroyd et al. (2009), appear directly after exposure to MS (PND10). Summarising, up-
regulation of GR in the PVN of ELS mice, is proposed to serve as an adaptation to a 
hyperactive HPA axis and, by increased signalling, it might compensate for reduced GR 
efficiency at other levels unidentified so far.   
Chronic stress in adulthood is another risk factor for the development of stress-related 
psychiatric disorders (Lupien et al. 2009). However, stress reactivity in adulthood may be 
modulated by previous stress experience, including early-life stress  (de Kloet et al. 2005). 
Importantly, recent studies in our laboratory (as shown in Bockmühl et al. submitted) suggest 
that postnatal exposure to ELS attenuates the deleterious consequences of adult chronic 
unpredictable stress (CUS), when compared to mice undergoing just one of these stress 
exposures (either ELS or CUS). The behavioural, endocrine and expression data (collected in 
Table 11) indicate that ELS x CUS mice cope better with certain adult stressors. That fact 
might be explained, at least partly, by ELS-mediated up-regulation of GR in the crh-positive 
neurons of the PVN. Altogether, the set of data presented here clearly indicates that elevated 
GR protein levels in the PVN result in increased GR signalling in mice with a history of MS 
and improved negative feedback regulation, when mice are exposured additionally to CUS 
during adulthood. 
Parameter mesaured ELS CUS ELSxCUS 
GR    
Avp    
Crh    
HPA axis function following acute stress    
GC feedback efficacy    
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Depression-like behavior    
Anxiety-like behavior    
Spatial learning    
 
Table 11: Synopsis of behavioural, endocrine, and expression data from Bockmühl et al. submitted 
The  behavioural, endocrine, and expression data of adult male mice after exposure to ELS, CUS or combined 
ELS x CUS.  
  
Altogether, these data suggest that ELS-dependent enhanced GR expression confers higher 
repression to the Crh gene and restrains CUS-induced Crh mRNA expression. Consequently, 
this might lead to normalised HPA axis responsiveness following acute stress, more efficient 
negative feedback inhibition and improvement of behavioural phenotypes induced by CUS 
(Bockmühl et al. submitted, Table 11). 
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Conclusion 
Summarizing, the results presented in this thesis, together with our previous studies, indicate 
that early life adversity influences brain functions later in life by alterations in HPA-axis 
activity. We report critical epigenetic changes at the GR promoter, which open the 
opportunity to better understand the molecular basis of programming and mal-programming 
in response to environmental signals and their contribution to the development of stress-
related psychiatric disorders.  
Moreover, conservation of CpG methylation within the YY1 binding site across neuronal and 
peripheral tissues in different mouse strains and human, strongly indicate a conserved 
mechanism of YY1-dependent regulation of human GR gene expression and warrant further 
investigations into this topic under different stress-related disease conditions.  
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